ONTOLOGY REPORT - ANNOTATIONS
|
elemental selenium
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | AIM1L | absent in melanoma 1-like |
|
increases expression | EXP | 1 | 26,648,350 | 26,680,621 | RGD:6480464 | CTD | |
| G | AIM1L | absent in melanoma 1-like |
|
multiple interactions | EXP | 1 | 26,648,350 | 26,680,621 | RGD:6480464 | CTD | |
| G | AIMP1 | aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
|
multiple interactions | EXP | 4 | 107,236,767 | 107,270,382 | RGD:6480464 | CTD | |
| G | AIMP1 | aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
|
decreases expression | EXP | 4 | 107,236,767 | 107,270,382 | RGD:6480464 | CTD | |
| G | ARPC1B | actin related protein 2/3 complex, subunit 1B, 41kDa |
|
increases expression | EXP | 7 | 98,972,298 | 98,992,424 | RGD:6480464 | CTD | |
| G | ARPC4 | actin related protein 2/3 complex, subunit 4, 20kDa |
|
increases expression | EXP | 3 | 9,834,179 | 9,848,789 | RGD:6480464 | CTD | |
| G | AS3MT | arsenic (+3 oxidation state) methyltransferase |
|
multiple interactions | EXP | 10 | 104,629,210 | 104,661,656 | RGD:6480464 | CTD | |
| G | ASAP3 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
|
increases expression | EXP | 1 | 23,755,056 | 23,810,750 | RGD:6480464 | CTD | |
| G | BLVRB | biliverdin reductase B (flavin reductase (NADPH)) |
|
increases expression | EXP | 19 | 40,953,691 | 40,971,725 | RGD:6480464 | CTD | |
| G | BRF2 | BRF2, RNA polymerase III transcription initiation factor 50 kDa subunit |
|
increases expression | EXP | 8 | 37,701,398 | 37,707,431 | RGD:6480464 | CTD | |
| G | BRMS1 | breast cancer metastasis suppressor 1 |
|
increases expression | EXP | 11 | 66,104,804 | 66,112,582 | RGD:6480464 | CTD | |
| G | BSCL2 | Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
|
multiple interactions | EXP | 11 | 62,457,734 | 62,477,091 | RGD:6480464 | CTD | |
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
multiple interactions | EXP | 17 | 32,582,296 | 32,584,222 | RGD:6480464 | CTD | |
| G | CCL3L1 | chemokine (C-C motif) ligand 3-like 1 |
|
increases expression | EXP | 17 | 34,623,842 | 34,625,730 | RGD:6480464 | CTD | |
| G | CCNB1 | cyclin B1 |
|
decreases expression | EXP | 5 | 68,462,837 | 68,474,072 | RGD:6480464 | CTD | |
| G | CCNC | cyclin C |
|
decreases expression | EXP | 6 | 99,990,263 | 100,016,690 | RGD:6480464 | CTD | |
| G | CEP170 | centrosomal protein 170kDa |
|
decreases expression | EXP | 1 | 243,287,730 | 243,418,708 | RGD:6480464 | CTD | |
| G | CLCN3 | chloride channel, voltage-sensitive 3 |
|
decreases expression | EXP | 4 | 170,541,672 | 170,644,338 | RGD:6480464 | CTD | |
| G | CLEC3B | C-type lectin domain family 3, member B |
|
increases expression | EXP | 3 | 45,067,759 | 45,077,563 | RGD:6480464 | CTD | |
| G | CLN3 | ceroid-lipofuscinosis, neuronal 3 |
|
multiple interactions | EXP | 16 | 28,488,600 | 28,503,623 | RGD:6480464 | CTD | |
| G | CLN3 | ceroid-lipofuscinosis, neuronal 3 |
|
increases expression | EXP | 16 | 28,488,600 | 28,503,623 | RGD:6480464 | CTD | |
| G | CUEDC2 | CUE domain containing 2 |
|
increases expression | EXP | 10 | 104,183,002 | 104,192,423 | RGD:6480464 | CTD | |
| G | CUL3 | cullin 3 |
|
decreases expression | EXP | 2 | 225,334,867 | 225,450,114 | RGD:6480464 | CTD | |
| G | CUL4A | cullin 4A |
|
multiple interactions | EXP | 13 | 113,863,086 | 113,919,392 | RGD:6480464 | CTD | |
| G | CUL7 | cullin 7 |
|
increases expression | EXP | 6 | 43,005,355 | 43,021,683 | RGD:6480464 | CTD | |
| G | CUTC | cutC copper transporter homolog (E. coli) |
|
multiple interactions | EXP | 10 | 101,491,958 | 101,515,894 | RGD:6480464 | CTD | |
| G | CUTC | cutC copper transporter homolog (E. coli) |
|
decreases expression | EXP | 10 | 101,491,958 | 101,515,894 | RGD:6480464 | CTD | |
| G | CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression | EXP | 4 | 74,735,109 | 74,737,019 | RGD:6480464 | CTD | |
| G | CXCL2 | chemokine (C-X-C motif) ligand 2 |
|
increases expression | EXP | 4 | 74,962,752 | 74,964,997 | RGD:6480464 | CTD | |
| G | CXCL9 | chemokine (C-X-C motif) ligand 9 |
|
decreases expression | EXP | 4 | 76,922,623 | 76,928,641 | RGD:6480464 | CTD | |
| G | DESI2 | desumoylating isopeptidase 2 |
|
decreases expression | EXP | 1 | 244,816,352 | 244,872,335 | RGD:6480464 | CTD | |
| G | DIO2 | deiodinase, iodothyronine, type II |
|
increases activity | ISO | 14 | 80,663,868 | 80,697,397 | RGD:6480464 | CTD | |
| G | DIP2C | DIP2 disco-interacting protein 2 homolog C (Drosophila) |
|
decreases expression | EXP | 10 | 320,130 | 735,608 | RGD:6480464 | CTD | |
| G | DLG1 | discs, large homolog 1 (Drosophila) |
|
decreases expression | EXP | 3 | 196,769,431 | 197,025,447 | RGD:6480464 | CTD | |
| G | DMTF1 | cyclin D binding myb-like transcription factor 1 |
|
multiple interactions | EXP | 7 | 86,781,677 | 86,825,648 | RGD:6480464 | CTD | |
| G | EPN2 | epsin 2 |
|
increases expression | EXP | 17 | 19,140,690 | 19,240,028 | RGD:6480464 | CTD | |
| G | ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
increases expression | EXP | 17 | 37,844,393 | 37,884,915 | RGD:6480464 | CTD | |
| G | ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
multiple interactions | EXP | 17 | 37,844,393 | 37,884,915 | RGD:6480464 | CTD | |
| G | ERCC1 | excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
|
increases expression | EXP | 19 | 45,910,591 | 45,927,177 | RGD:6480464 | CTD | |
| G | FGFR1 | fibroblast growth factor receptor 1 |
|
increases expression | EXP | 8 | 38,268,656 | 38,326,352 | RGD:6480464 | CTD | |
| G | FGG | fibrinogen gamma chain |
|
multiple interactions | ISO | 4 | 155,525,286 | 155,533,902 | RGD:6480464 | CTD | |
| G | FHOD3 | formin homology 2 domain containing 3 |
|
decreases expression | EXP | 18 | 33,877,702 | 34,360,018 | RGD:6480464 | CTD | |
| G | FIG4 | FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae) |
|
multiple interactions | EXP | 6 | 110,012,424 | 110,146,634 | RGD:6480464 | CTD | |
| G | FIG4 | FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae) |
|
decreases expression | EXP | 6 | 110,012,424 | 110,146,634 | RGD:6480464 | CTD | |
| G | GOSR1 | golgi SNAP receptor complex member 1 |
|
decreases expression | EXP | 17 | 28,804,426 | 28,853,832 | RGD:6480464 | CTD | |
| G | GPI | glucose-6-phosphate isomerase |
|
increases expression | EXP | 19 | 34,855,645 | 34,893,318 | RGD:6480464 | CTD | |
| G | GPKOW | G patch domain and KOW motifs |
|
increases expression | EXP | X | 48,969,022 | 48,980,079 | RGD:6480464 | CTD | |
| G | GPR107 | G protein-coupled receptor 107 |
|
increases expression | EXP | 9 | 132,815,985 | 132,902,448 | RGD:6480464 | CTD | |
| G | GTF2H2 | general transcription factor IIH, polypeptide 2, 44kDa |
|
decreases expression | EXP | 5 | 70,330,951 | 70,363,497 | RGD:6480464 | CTD | |
| G | GTF3C1 | general transcription factor IIIC, polypeptide 1, alpha 220kDa |
|
increases expression | EXP | 16 | 27,471,934 | 27,561,251 | RGD:6480464 | CTD | |
| G | GTPBP8 | GTP-binding protein 8 (putative) |
|
multiple interactions | EXP | 3 | 112,709,800 | 112,720,221 | RGD:6480464 | CTD | |
| G | GTPBP8 | GTP-binding protein 8 (putative) |
|
decreases expression | EXP | 3 | 112,709,800 | 112,720,221 | RGD:6480464 | CTD | |
| G | HSD11B2 | hydroxysteroid (11-beta) dehydrogenase 2 |
|
multiple interactions | ISO | 16 | 67,465,036 | 67,471,456 | RGD:6480464 | CTD | |
| G | HSD17B11 | hydroxysteroid (17-beta) dehydrogenase 11 |
|
increases expression | ISO | 4 | 88,257,691 | 88,312,455 | RGD:6480464 | CTD | |
| G | HSD17B8 | hydroxysteroid (17-beta) dehydrogenase 8 |
|
increases expression | EXP | 6 | 33,172,414 | 33,174,608 | RGD:6480464 | CTD | |
| G | HSD3B2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
increases expression | ISO | 1 | 119,957,554 | 119,965,662 | RGD:6480464 | CTD | |
| G | INTS6 | integrator complex subunit 6 |
|
decreases expression | EXP | 13 | 51,935,701 | 52,027,275 | RGD:6480464 | CTD | |
| G | IQCB1 | IQ motif containing B1 |
|
decreases expression | EXP | 3 | 121,488,610 | 121,553,926 | RGD:6480464 | CTD | |
| G | IQCK | IQ motif containing K |
|
decreases expression | EXP | 16 | 19,727,778 | 19,868,861 | RGD:6480464 | CTD | |
| G | IQCK | IQ motif containing K |
|
multiple interactions | EXP | 16 | 19,727,778 | 19,868,861 | RGD:6480464 | CTD | |
| G | IRF3 | interferon regulatory factor 3 |
|
increases expression | EXP | 19 | 50,162,826 | 50,169,132 | RGD:6480464 | CTD | |
| G | KRR1 | KRR1, small subunit (SSU) processome component, homolog (yeast) |
|
decreases expression | EXP | 12 | 75,891,419 | 75,905,418 | RGD:6480464 | CTD | |
| G | LRRC47 | leucine rich repeat containing 47 |
|
multiple interactions | EXP | 1 | 3,696,784 | 3,713,068 | RGD:6480464 | CTD | |
| G | LRRFIP1 | leucine rich repeat (in FLII) interacting protein 1 |
|
decreases expression | EXP | 2 | 238,536,224 | 238,690,290 | RGD:6480464 | CTD | |
| G | LSP1 | lymphocyte-specific protein 1 |
|
increases expression | EXP | 11 | 1,874,200 | 1,913,493 | RGD:6480464 | CTD | |
| G | LSR | lipolysis stimulated lipoprotein receptor |
|
increases expression | EXP | 19 | 35,739,559 | 35,758,867 | RGD:6480464 | CTD | |
| G | MFAP2 | microfibrillar-associated protein 2 |
|
increases expression | EXP | 1 | 17,300,997 | 17,308,081 | RGD:6480464 | CTD | |
| G | MGAT1 | mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
increases expression | EXP | 5 | 180,217,541 | 180,237,137 | RGD:6480464 | CTD | |
| G | MGP | matrix Gla protein |
|
increases expression | EXP | 12 | 15,034,115 | 15,038,853 | RGD:6480464 | CTD | |
| G | MIIP | migration and invasion inhibitory protein |
|
increases expression | EXP | 1 | 12,079,299 | 12,092,106 | RGD:6480464 | CTD | |
| G | MSRB1 | methionine sulfoxide reductase B1 |
|
multiple interactions | ISO | 16 | 1,988,234 | 1,993,294 | RGD:6480464 | CTD | |
| G | MSRB1 | methionine sulfoxide reductase B1 |
|
decreases expression | ISO | 16 | 1,988,234 | 1,993,294 | RGD:6480464 | CTD | |
| G | NAGK | N-acetylglucosamine kinase |
|
increases expression | EXP | 2 | 71,295,408 | 71,305,998 | RGD:6480464 | CTD | |
| G | NAGLU | N-acetylglucosaminidase, alpha |
|
increases expression | EXP | 17 | 40,687,951 | 40,696,467 | RGD:6480464 | CTD | |
| G | NANOG | Nanog homeobox |
|
increases expression | EXP | 12 | 7,941,995 | 7,948,655 | RGD:6480464 | CTD | |
| G | NAPA | N-ethylmaleimide-sensitive factor attachment protein, alpha |
|
increases expression | EXP | 19 | 47,990,891 | 48,018,515 | RGD:6480464 | CTD | |
| G | NCDN | neurochondrin |
|
multiple interactions | EXP | 1 | 36,023,393 | 36,032,380 | RGD:6480464 | CTD | |
| G | NDUFB2 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa |
|
decreases expression | EXP | 7 | 140,396,481 | 140,406,446 | RGD:6480464 | CTD | |
| G | NDUFS3 | NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase) |
|
increases expression | EXP | 11 | 47,600,562 | 47,606,115 | RGD:6480464 | CTD | |
| G | NDUFS4 | NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) |
|
decreases expression | EXP | 5 | 52,856,465 | 52,979,171 | RGD:6480464 | CTD | |
| G | NDUFV1 | NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa |
|
increases expression | EXP | 11 | 67,374,323 | 67,380,012 | RGD:6480464 | CTD | |
| G | NEDD8 | neural precursor cell expressed, developmentally down-regulated 8 |
|
multiple interactions | EXP | 14 | 24,686,057 | 24,701,576 | RGD:6480464 | CTD | |
| G | NEK1 | NIMA-related kinase 1 |
|
decreases expression | EXP | 4 | 170,314,421 | 170,533,778 | RGD:6480464 | CTD | |
| G | NEK1 | NIMA-related kinase 1 |
|
multiple interactions | EXP | 4 | 170,314,421 | 170,533,778 | RGD:6480464 | CTD | |
| G | NEK2 | NIMA-related kinase 2 |
|
multiple interactions | EXP | 1 | 211,831,598 | 211,848,972 | RGD:6480464 | CTD | |
| G | NEK2 | NIMA-related kinase 2 |
|
decreases expression | EXP | 1 | 211,831,598 | 211,848,972 | RGD:6480464 | CTD | |
| G | NELFA | negative elongation factor complex member A |
|
multiple interactions | EXP | 4 | 1,984,441 | 2,010,962 | RGD:6480464 | CTD | |
| G | NELFA | negative elongation factor complex member A |
|
increases expression | EXP | 4 | 1,984,441 | 2,010,962 | RGD:6480464 | CTD | |
| G | NES | nestin |
|
increases expression | EXP | 1 | 156,638,555 | 156,647,189 | RGD:6480464 | CTD | |
| G | NF2 | neurofibromin 2 (merlin) |
|
multiple interactions | EXP | 22 | 29,999,545 | 30,094,589 | RGD:6480464 | CTD | |
| G | NF2 | neurofibromin 2 (merlin) |
|
increases expression | EXP | 22 | 29,999,545 | 30,094,589 | RGD:6480464 | CTD | |
| G | NFAT5 | nuclear factor of activated T-cells 5, tonicity-responsive |
|
multiple interactions | EXP | 16 | 69,599,869 | 69,738,569 | RGD:6480464 | CTD | |
| G | NFAT5 | nuclear factor of activated T-cells 5, tonicity-responsive |
|
decreases expression | EXP | 16 | 69,599,869 | 69,738,569 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
decreases expression | EXP | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions | EXP | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
affects activity | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFIC | nuclear factor I/C (CCAAT-binding transcription factor) |
|
increases expression | EXP | 19 | 3,359,561 | 3,469,215 | RGD:6480464 | CTD | |
| G | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions | ISO | 14 | 35,870,716 | 35,873,960 | RGD:6480464 | CTD | |
| G | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions | ISO | 14 | 35,870,716 | 35,873,960 | RGD:6480464 | CTD | |
| G | NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
increases expression | EXP | 19 | 39,390,340 | 39,399,534 | RGD:6480464 | CTD | |
| G | NFS1 | NFS1 nitrogen fixation 1 homolog (S. cerevisiae) |
|
decreases expression | EXP | 20 | 34,256,610 | 34,287,287 | RGD:6480464 | CTD | |
| G | NHP2L1 | NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae) |
|
increases expression | EXP | 22 | 42,069,937 | 42,084,913 | RGD:6480464 | CTD | |
| G | NID2 | nidogen 2 (osteonidogen) |
|
decreases expression | EXP | 14 | 52,471,520 | 52,535,946 | RGD:6480464 | CTD | |
| G | NINJ1 | ninjurin 1 |
|
increases expression | EXP | 9 | 95,883,771 | 95,896,570 | RGD:6480464 | CTD | |
| G | NIPBL | Nipped-B homolog (Drosophila) |
|
decreases expression | EXP | 5 | 36,876,861 | 37,065,921 | RGD:6480464 | CTD | |
| G | NKTR | natural killer-tumor recognition sequence |
|
decreases expression | EXP | 3 | 42,642,147 | 42,690,233 | RGD:6480464 | CTD | |
| G | NLGN4Y | neuroligin 4, Y-linked |
|
increases expression | EXP | Y | 16,634,488 | 16,955,848 | RGD:6480464 | CTD | |
| G | NLRP3 | NLR family, pyrin domain containing 3 |
|
increases expression | EXP | 1 | 247,579,458 | 247,612,410 | RGD:6480464 | CTD | |
| G | NOC3L | nucleolar complex associated 3 homolog (S. cerevisiae) |
|
decreases expression | EXP | 10 | 96,092,989 | 96,122,683 | RGD:6480464 | CTD | |
| G | NOL3 | nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
multiple interactions | EXP | 16 | 67,204,405 | 67,209,643 | RGD:6480464 | CTD | |
| G | NOL8 | nucleolar protein 8 |
|
multiple interactions | EXP | 9 | 95,059,640 | 95,087,876 | RGD:6480464 | CTD | |
| G | NOL8 | nucleolar protein 8 |
|
decreases expression | EXP | 9 | 95,059,640 | 95,087,876 | RGD:6480464 | CTD | |
| G | NOLC1 | nucleolar and coiled-body phosphoprotein 1 |
|
multiple interactions | EXP | 10 | 103,911,933 | 103,923,627 | RGD:6480464 | CTD | |
| G | NOMO3 | NODAL modulator 3 |
|
increases expression | EXP | 16 | 16,326,389 | 16,388,668 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
multiple interactions | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
multiple interactions | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOSIP | nitric oxide synthase interacting protein |
|
multiple interactions | EXP | 19 | 50,058,725 | 50,083,829 | RGD:6480464 | CTD | |
| G | NOTCH3 | notch 3 |
|
increases expression | EXP | 19 | 15,270,444 | 15,311,792 | RGD:6480464 | CTD | |
| G | NOX4 | NADPH oxidase 4 |
|
increases expression | ISO | 11 | 89,057,521 | 89,322,779 | RGD:6480464 | CTD | |
| G | NPEPL1 | aminopeptidase-like 1 |
|
multiple interactions | EXP | 20 | 57,264,187 | 57,290,900 | RGD:6480464 | CTD | |
| G | NPEPL1 | aminopeptidase-like 1 |
|
increases expression | EXP | 20 | 57,264,187 | 57,290,900 | RGD:6480464 | CTD | |
| G | NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
|
multiple interactions | ISO | 5 | 170,814,708 | 170,837,888 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
affects activity | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases expression | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NR2C1 | nuclear receptor subfamily 2, group C, member 1 |
|
decreases expression | EXP | 12 | 95,414,005 | 95,467,404 | RGD:6480464 | CTD | |
| G | NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
decreases expression | EXP | 5 | 142,657,496 | 142,815,077 | RGD:6480464 | CTD | |
| G | NRF1 | nuclear respiratory factor 1 |
|
multiple interactions | ISO | 7 | 129,251,555 | 129,396,922 | RGD:6480464 | CTD | |
| G | NRF1 | nuclear respiratory factor 1 |
|
increases expression | ISO | 7 | 129,251,555 | 129,396,922 | RGD:6480464 | CTD | |
| G | NSMAF | neutral sphingomyelinase (N-SMase) activation associated factor |
|
decreases expression | EXP | 8 | 59,496,063 | 59,572,404 | RGD:6480464 | CTD | |
| G | NSMCE2 | non-SMC element 2, MMS21 homolog (S. cerevisiae) |
|
increases expression | EXP | 8 | 126,104,083 | 126,379,367 | RGD:6480464 | CTD | |
| G | NT5DC2 | 5'-nucleotidase domain containing 2 |
|
multiple interactions | EXP | 3 | 52,558,385 | 52,569,093 | RGD:6480464 | CTD | |
| G | NT5DC2 | 5'-nucleotidase domain containing 2 |
|
increases expression | EXP | 3 | 52,558,385 | 52,569,093 | RGD:6480464 | CTD | |
| G | NUCB1 | nucleobindin 1 |
|
increases expression | EXP | 19 | 49,403,307 | 49,426,540 | RGD:6480464 | CTD | |
| G | NUDC | nuclear distribution C homolog (A. nidulans) |
|
increases expression | EXP | 1 | 27,248,213 | 27,273,362 | RGD:6480464 | CTD | |
| G | NUP93 | nucleoporin 93kDa |
|
increases expression | EXP | 16 | 56,764,017 | 56,878,862 | RGD:6480464 | CTD | |
| G | NUTF2 | nuclear transport factor 2 |
|
increases expression | EXP | 16 | 67,880,819 | 67,905,219 | RGD:6480464 | CTD | |
| G | OAZ1 | ornithine decarboxylase antizyme 1 |
|
increases expression | EXP | 19 | 2,269,520 | 2,273,487 | RGD:6480464 | CTD | |
| G | OAZ2 | ornithine decarboxylase antizyme 2 |
|
increases expression | EXP | 15 | 64,979,773 | 64,995,462 | RGD:6480464 | CTD | |
| G | OBSL1 | obscurin-like 1 |
|
increases expression | EXP | 2 | 220,415,450 | 220,436,268 | RGD:6480464 | CTD | |
| G | OCLN | occludin |
|
multiple interactions | EXP | 5 | 68,788,119 | 68,853,931 | RGD:6480464 | CTD | |
| G | OGFR | opioid growth factor receptor |
|
multiple interactions | EXP | 20 | 61,436,177 | 61,445,352 | RGD:6480464 | CTD | |
| G | OGFR | opioid growth factor receptor |
|
increases expression | EXP | 20 | 61,436,177 | 61,445,352 | RGD:6480464 | CTD | |
| G | OGG1 | 8-oxoguanine DNA glycosylase |
|
multiple interactions | EXP | 3 | 9,791,628 | 9,808,353 | RGD:6480464 | CTD | |
| G | OGG1 | 8-oxoguanine DNA glycosylase |
|
increases expression | EXP | 3 | 9,791,628 | 9,808,353 | RGD:6480464 | CTD | |
| G | OLA1 | Obg-like ATPase 1 |
|
decreases expression | EXP | 2 | 174,937,175 | 175,113,365 | RGD:6480464 | CTD | |
| G | OPA1 | optic atrophy 1 (autosomal dominant) |
|
decreases expression | EXP | 3 | 193,310,933 | 193,415,600 | RGD:6480464 | CTD | |
| G | OPTN | optineurin |
|
increases expression | EXP | 10 | 13,142,082 | 13,180,276 | RGD:6480464 | CTD | |
| G | ORM1 | orosomucoid 1 |
|
multiple interactions | ISO | 9 | 117,085,303 | 117,088,759 | RGD:6480464 | CTD | |
| G | OS9 | osteosarcoma amplified 9, endoplasmic reticulum lectin |
|
increases expression | EXP | 12 | 58,087,738 | 58,115,340 | RGD:6480464 | CTD | |
| G | OSBP2 | oxysterol binding protein 2 |
|
increases expression | EXP | 22 | 31,090,793 | 31,303,811 | RGD:6480464 | CTD | |
| G | OSBPL1A | oxysterol binding protein-like 1A |
|
multiple interactions | EXP | 18 | 21,742,009 | 21,977,833 | RGD:6480464 | CTD | |
| G | OSBPL1A | oxysterol binding protein-like 1A |
|
decreases expression | EXP | 18 | 21,742,009 | 21,977,833 | RGD:6480464 | CTD | |
| G | OSGEP | O-sialoglycoprotein endopeptidase |
|
increases expression | EXP | 14 | 20,915,207 | 20,923,267 | RGD:6480464 | CTD | |
| G | OVGP1 | oviductal glycoprotein 1, 120kDa |
|
multiple interactions | EXP | 1 | 111,956,937 | 111,970,399 | RGD:6480464 | CTD | |
| G | OVGP1 | oviductal glycoprotein 1, 120kDa |
|
increases expression | EXP | 1 | 111,956,937 | 111,970,399 | RGD:6480464 | CTD | |
| G | PA2G4 | proliferation-associated 2G4, 38kDa |
|
multiple interactions | EXP | 12 | 56,498,103 | 56,507,694 | RGD:6480464 | CTD | |
| G | PAFAH1B1 | platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) |
|
multiple interactions | EXP | 17 | 2,496,923 | 2,588,909 | RGD:6480464 | CTD | |
| G | PAFAH1B3 | platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) |
|
increases expression | EXP | 19 | 42,801,185 | 42,806,952 | RGD:6480464 | CTD | |
| G | PAGE4 | P antigen family, member 4 (prostate associated) |
|
decreases expression | EXP | X | 49,593,906 | 49,598,570 | RGD:6480464 | CTD | |
| G | PAK4 | p21 protein (Cdc42/Rac)-activated kinase 4 |
|
increases expression | EXP | 19 | 39,616,420 | 39,670,046 | RGD:6480464 | CTD | |
| G | PALLD | palladin, cytoskeletal associated protein |
|
decreases expression | EXP | 4 | 169,418,217 | 169,849,608 | RGD:6480464 | CTD | |
| G | PALM2 | paralemmin 2 |
|
increases expression | EXP | 9 | 112,403,068 | 112,713,756 | RGD:6480464 | CTD | |
| G | PAM | peptidylglycine alpha-amidating monooxygenase |
|
decreases expression | EXP | 5 | 102,201,527 | 102,366,809 | RGD:6480464 | CTD | |
| G | PANK4 | pantothenate kinase 4 |
|
increases expression | EXP | 1 | 2,439,975 | 2,458,035 | RGD:6480464 | CTD | |
| G | PAOX | polyamine oxidase (exo-N4-amino) |
|
multiple interactions | EXP | 10 | 135,192,741 | 135,205,198 | RGD:6480464 | CTD | |
| G | PARP1 | poly (ADP-ribose) polymerase 1 |
|
multiple interactions | EXP | 1 | 226,548,392 | 226,595,801 | RGD:6480464 | CTD | |
| G | PC | pyruvate carboxylase |
|
increases expression | EXP | 11 | 66,615,997 | 66,725,847 | RGD:6480464 | CTD | |
| G | PCBP1 | poly(rC) binding protein 1 |
|
increases expression | EXP | 2 | 70,314,585 | 70,316,335 | RGD:6480464 | CTD | |
| G | PCDHGC3 | protocadherin gamma subfamily C, 3 |
|
increases expression | EXP | 5 | 140,855,569 | 140,892,546 | RGD:6480464 | CTD | |
| G | PCM1 | pericentriolar material 1 |
|
decreases expression | EXP | 8 | 17,780,366 | 17,887,457 | RGD:6480464 | CTD | |
| G | PCNA | proliferating cell nuclear antigen |
|
decreases expression | EXP | 20 | 5,095,599 | 5,107,268 | RGD:6480464 | CTD | |
| G | PCOLCE | procollagen C-endopeptidase enhancer |
|
increases expression | EXP | 7 | 100,199,882 | 100,205,798 | RGD:6480464 | CTD | |
| G | PCP4 | Purkinje cell protein 4 |
|
decreases expression | EXP | 21 | 41,239,347 | 41,301,322 | RGD:6480464 | CTD | |
| G | PCSK5 | proprotein convertase subtilisin/kexin type 5 |
|
decreases expression | EXP | 9 | 78,505,560 | 78,977,255 | RGD:6480464 | CTD | |
| G | PCSK7 | proprotein convertase subtilisin/kexin type 7 |
|
multiple interactions | EXP | 11 | 117,075,788 | 117,102,811 | RGD:6480464 | CTD | |
| G | PCSK7 | proprotein convertase subtilisin/kexin type 7 |
|
increases expression | EXP | 11 | 117,075,788 | 117,102,811 | RGD:6480464 | CTD | |
| G | PCYOX1L | prenylcysteine oxidase 1 like |
|
multiple interactions | EXP | 5 | 148,737,570 | 148,749,221 | RGD:6480464 | CTD | |
| G | PCYOX1L | prenylcysteine oxidase 1 like |
|
decreases expression | EXP | 5 | 148,737,570 | 148,749,221 | RGD:6480464 | CTD | |
| G | PDE8A | phosphodiesterase 8A |
|
multiple interactions | EXP | 15 | 85,523,744 | 85,682,376 | RGD:6480464 | CTD | |
| G | PDE8A | phosphodiesterase 8A |
|
decreases expression | EXP | 15 | 85,523,744 | 85,682,376 | RGD:6480464 | CTD | |
| G | PDGFA | platelet-derived growth factor alpha polypeptide |
|
multiple interactions | EXP | 7 | 536,895 | 559,481 | RGD:6480464 | CTD | |
| G | PDLIM7 | PDZ and LIM domain 7 (enigma) |
|
increases expression | EXP | 5 | 176,910,395 | 176,924,602 | RGD:6480464 | CTD | |
| G | PDPK1 | 3-phosphoinositide dependent protein kinase-1 |
|
multiple interactions | EXP | 16 | 2,587,965 | 2,653,191 | RGD:6480464 | CTD | |
| G | PDSS2 | prenyl (decaprenyl) diphosphate synthase, subunit 2 |
|
decreases expression | EXP | 6 | 107,473,761 | 107,780,779 | RGD:6480464 | CTD | |
| G | PEA15 | phosphoprotein enriched in astrocytes 15 |
|
increases expression | EXP | 1 | 160,175,125 | 160,185,162 | RGD:6480464 | CTD | |
| G | PEF1 | penta-EF-hand domain containing 1 |
|
increases expression | EXP | 1 | 32,095,463 | 32,110,838 | RGD:6480464 | CTD | |
| G | PER3 | period circadian clock 3 |
|
decreases expression | EXP | 1 | 7,844,763 | 7,905,237 | RGD:6480464 | CTD | |
| G | PES1 | pescadillo ribosomal biogenesis factor 1 |
|
multiple interactions | EXP | 22 | 30,972,612 | 31,003,000 | RGD:6480464 | CTD | |
| G | PES1 | pescadillo ribosomal biogenesis factor 1 |
|
increases expression | EXP | 22 | 30,972,612 | 31,003,000 | RGD:6480464 | CTD | |
| G | PEX1 | peroxisomal biogenesis factor 1 |
|
decreases expression | EXP | 7 | 92,116,337 | 92,157,845 | RGD:6480464 | CTD | |
| G | PEX14 | peroxisomal biogenesis factor 14 |
|
increases expression | EXP | 1 | 10,535,003 | 10,690,815 | RGD:6480464 | CTD | |
| G | PEX3 | peroxisomal biogenesis factor 3 |
|
multiple interactions | EXP | 6 | 143,771,918 | 143,811,753 | RGD:6480464 | CTD | |
| G | PEX3 | peroxisomal biogenesis factor 3 |
|
decreases expression | EXP | 6 | 143,771,918 | 143,811,753 | RGD:6480464 | CTD | |
| G | PEX7 | peroxisomal biogenesis factor 7 |
|
multiple interactions | EXP | 6 | 137,143,702 | 137,235,072 | RGD:6480464 | CTD | |
| G | PFKL | phosphofructokinase, liver |
|
increases expression | EXP | 21 | 45,719,925 | 45,747,261 | RGD:6480464 | CTD | |
| G | PFN1 | profilin 1 |
|
multiple interactions | EXP | 17 | 4,848,945 | 4,852,381 | RGD:6480464 | CTD | |
| G | PFN1 | profilin 1 |
|
increases expression | EXP | 17 | 4,848,945 | 4,852,381 | RGD:6480464 | CTD | |
| G | PGAP1 | post-GPI attachment to proteins 1 |
|
decreases expression | EXP | 2 | 197,697,728 | 197,791,454 | RGD:6480464 | CTD | |
| G | PGAP2 | post-GPI attachment to proteins 2 |
|
multiple interactions | EXP | 11 | 3,818,954 | 3,847,601 | RGD:6480464 | CTD | |
| G | PGAP2 | post-GPI attachment to proteins 2 |
|
increases expression | EXP | 11 | 3,818,954 | 3,847,601 | RGD:6480464 | CTD | |
| G | PGM3 | phosphoglucomutase 3 |
|
multiple interactions | EXP | 6 | 83,874,592 | 83,903,655 | RGD:6480464 | CTD | |
| G | PGM3 | phosphoglucomutase 3 |
|
decreases expression | EXP | 6 | 83,874,592 | 83,903,655 | RGD:6480464 | CTD | |
| G | PHACTR2 | phosphatase and actin regulator 2 |
|
decreases expression | EXP | 6 | 143,929,317 | 144,152,322 | RGD:6480464 | CTD | |
| G | PHF3 | PHD finger protein 3 |
|
decreases expression | EXP | 6 | 64,356,431 | 64,424,405 | RGD:6480464 | CTD | |
| G | PHLDA1 | pleckstrin homology-like domain, family A, member 1 |
|
multiple interactions | EXP | 12 | 76,419,227 | 76,425,556 | RGD:6480464 | CTD | |
| G | PIAS4 | protein inhibitor of activated STAT, 4 |
|
multiple interactions | EXP | 19 | 4,007,749 | 4,038,067 | RGD:6480464 | CTD | |
| G | PIEZO1 | piezo-type mechanosensitive ion channel component 1 |
|
increases expression | EXP | 16 | 88,781,746 | 88,851,372 | RGD:6480464 | CTD | |
| G | PIGG | phosphatidylinositol glycan anchor biosynthesis, class G |
|
decreases expression | EXP | 4 | 492,989 | 533,320 | RGD:6480464 | CTD | |
| G | PIGK | phosphatidylinositol glycan anchor biosynthesis, class K |
|
decreases expression | EXP | 1 | 77,554,666 | 77,685,132 | RGD:6480464 | CTD | |
| G | PIGP | phosphatidylinositol glycan anchor biosynthesis, class P |
|
decreases expression | EXP | 21 | 38,437,664 | 38,445,458 | RGD:6480464 | CTD | |
| G | PIH1D1 | PIH1 domain containing 1 |
|
increases expression | EXP | 19 | 49,949,550 | 49,955,115 | RGD:6480464 | CTD | |
| G | PIH1D1 | PIH1 domain containing 1 |
|
multiple interactions | EXP | 19 | 49,949,550 | 49,955,115 | RGD:6480464 | CTD | |
| G | PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
|
increases expression | EXP | 1 | 9,711,790 | 9,789,172 | RGD:6480464 | CTD | |
| G | PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
|
multiple interactions | EXP | 1 | 9,711,790 | 9,789,172 | RGD:6480464 | CTD | |
| G | PITPNA | phosphatidylinositol transfer protein, alpha |
|
multiple interactions | EXP | 17 | 1,421,283 | 1,466,110 | RGD:6480464 | CTD | |
| G | PITPNA | phosphatidylinositol transfer protein, alpha |
|
increases expression | EXP | 17 | 1,421,283 | 1,466,110 | RGD:6480464 | CTD | |
| G | PITPNM1 | phosphatidylinositol transfer protein, membrane-associated 1 |
|
increases expression | EXP | 11 | 67,259,239 | 67,272,843 | RGD:6480464 | CTD | |
| G | PITX1 | paired-like homeodomain 1 |
|
multiple interactions | EXP | 5 | 134,363,424 | 134,369,964 | RGD:6480464 | CTD | |
| G | PITX1 | paired-like homeodomain 1 |
|
increases expression | EXP | 5 | 134,363,424 | 134,369,964 | RGD:6480464 | CTD | |
| G | PJA1 | praja ring finger 1, E3 ubiquitin protein ligase |
|
increases expression | EXP | X | 68,380,581 | 68,385,365 | RGD:6480464 | CTD | |
| G | PKD1 | polycystic kidney disease 1 (autosomal dominant) |
|
increases expression | EXP | 16 | 2,138,711 | 2,185,899 | RGD:6480464 | CTD | |
| G | PKM | pyruvate kinase, muscle |
|
increases expression | EXP | 15 | 72,491,370 | 72,523,727 | RGD:6480464 | CTD | |
| G | PKN2 | protein kinase N2 |
|
decreases expression | EXP | 1 | 89,149,922 | 89,301,938 | RGD:6480464 | CTD | |
| G | PLA2G12A | phospholipase A2, group XIIA |
|
multiple interactions | EXP | 4 | 110,631,145 | 110,651,242 | RGD:6480464 | CTD | |
| G | PLA2G12A | phospholipase A2, group XIIA |
|
decreases expression | EXP | 4 | 110,631,145 | 110,651,242 | RGD:6480464 | CTD | |
| G | PLA2G16 | phospholipase A2, group XVI |
|
increases expression | EXP | 11 | 63,341,934 | 63,381,941 | RGD:6480464 | CTD | |
| G | PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) |
|
increases expression | EXP | 1 | 20,301,924 | 20,306,932 | RGD:6480464 | CTD | |
| G | PLCB4 | phospholipase C, beta 4 |
|
multiple interactions | EXP | 20 | 9,049,701 | 9,461,463 | RGD:6480464 | CTD | |
| G | PLCB4 | phospholipase C, beta 4 |
|
decreases expression | EXP | 20 | 9,049,701 | 9,461,463 | RGD:6480464 | CTD | |
| G | PLEC | plectin |
|
increases expression | EXP | 8 | 144,989,321 | 145,050,913 | RGD:6480464 | CTD | |
| G | PLEKHA5 | pleckstrin homology domain containing, family A member 5 |
|
decreases expression | EXP | 12 | 19,282,626 | 19,529,334 | RGD:6480464 | CTD | |
| G | PLEKHJ1 | pleckstrin homology domain containing, family J member 1 |
|
increases expression | EXP | 19 | 2,233,155 | 2,236,328 | RGD:6480464 | CTD | |
| G | PLEKHO1 | pleckstrin homology domain containing, family O member 1 |
|
increases expression | EXP | 1 | 150,122,170 | 150,131,825 | RGD:6480464 | CTD | |
| G | PLLP | plasmolipin |
|
increases expression | EXP | 16 | 57,290,009 | 57,318,584 | RGD:6480464 | CTD | |
| G | PLOD2 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 |
|
decreases expression | EXP | 3 | 145,787,227 | 145,879,282 | RGD:6480464 | CTD | |
| G | PLVAP | plasmalemma vesicle associated protein |
|
increases expression | EXP | 19 | 17,462,264 | 17,488,137 | RGD:6480464 | CTD | |
| G | PLXNB2 | plexin B2 |
|
increases expression | EXP | 22 | 50,713,408 | 50,746,001 | RGD:6480464 | CTD | |
| G | PML | promyelocytic leukemia |
|
multiple interactions | EXP | 15 | 74,287,014 | 74,340,160 | RGD:6480464 | CTD | |
| G | PML | promyelocytic leukemia |
|
increases expression | EXP | 15 | 74,287,014 | 74,340,160 | RGD:6480464 | CTD | |
| G | PMPCB | peptidase (mitochondrial processing) beta |
|
decreases expression | EXP | 7 | 102,937,873 | 102,955,133 | RGD:6480464 | CTD | |
| G | PMS1 | PMS1 postmeiotic segregation increased 1 (S. cerevisiae) |
|
decreases expression | EXP | 2 | 190,648,811 | 190,742,355 | RGD:6480464 | CTD | |
| G | PNISR | PNN-interacting serine/arginine-rich protein |
|
decreases expression | EXP | 6 | 99,847,840 | 99,873,207 | RGD:6480464 | CTD | |
| G | PNKP | polynucleotide kinase 3'-phosphatase |
|
increases expression | EXP | 19 | 50,364,460 | 50,370,822 | RGD:6480464 | CTD | |
| G | PNPLA6 | patatin-like phospholipase domain containing 6 |
|
increases expression | EXP | 19 | 7,599,038 | 7,626,653 | RGD:6480464 | CTD | |
| G | POLA2 | polymerase (DNA directed), alpha 2, accessory subunit |
|
increases expression | EXP | 11 | 65,029,432 | 65,065,088 | RGD:6480464 | CTD | |
| G | POLDIP3 | polymerase (DNA-directed), delta interacting protein 3 |
|
increases expression | EXP | 22 | 42,979,727 | 43,010,962 | RGD:6480464 | CTD | |
| G | POLL | polymerase (DNA directed), lambda |
|
multiple interactions | EXP | 10 | 103,338,639 | 103,348,027 | RGD:6480464 | CTD | |
| G | POLL | polymerase (DNA directed), lambda |
|
increases expression | EXP | 10 | 103,338,639 | 103,348,027 | RGD:6480464 | CTD | |
| G | POLR2A | polymerase (RNA) II (DNA directed) polypeptide A, 220kDa |
|
increases expression | EXP | 17 | 7,387,698 | 7,417,935 | RGD:6480464 | CTD | |
| G | POLR2C | polymerase (RNA) II (DNA directed) polypeptide C, 33kDa |
|
increases expression | EXP | 16 | 57,496,551 | 57,505,921 | RGD:6480464 | CTD | |
| G | POLR2K | polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa |
|
decreases expression | EXP | 8 | 101,162,839 | 101,166,230 | RGD:6480464 | CTD | |
| G | POLR2M | polymerase (RNA) II (DNA directed) polypeptide M |
|
decreases expression | EXP | 15 | 57,998,901 | 58,009,753 | RGD:6480464 | CTD | |
| G | PON2 | paraoxonase 2 |
|
decreases expression | EXP | 7 | 95,034,174 | 95,064,384 | RGD:6480464 | CTD | |
| G | POR | P450 (cytochrome) oxidoreductase |
|
increases expression | EXP | 7 | 75,544,420 | 75,616,173 | RGD:6480464 | CTD | |
| G | POSTN | periostin, osteoblast specific factor |
|
decreases expression | EXP | 13 | 38,136,719 | 38,172,981 | RGD:6480464 | CTD | |
| G | POU5F1 | POU class 5 homeobox 1 |
|
increases expression | EXP | 6 | 31,132,114 | 31,138,451 | RGD:6480464 | CTD | |
| G | PPAP2B | phosphatidic acid phosphatase type 2B |
|
decreases expression | EXP | 1 | 56,960,419 | 57,045,257 | RGD:6480464 | CTD | |
| G | PPARG | peroxisome proliferator-activated receptor gamma |
|
multiple interactions | ISO | 3 | 12,329,349 | 12,475,855 | RGD:6480464 | CTD | |
| G | PPAT | phosphoribosyl pyrophosphate amidotransferase |
|
multiple interactions | EXP | 4 | 57,259,528 | 57,301,802 | RGD:6480464 | CTD | |
| G | PPAT | phosphoribosyl pyrophosphate amidotransferase |
|
decreases expression | EXP | 4 | 57,259,528 | 57,301,802 | RGD:6480464 | CTD | |
| G | PPFIBP1 | PTPRF interacting protein, binding protein 1 (liprin beta 1) |
|
decreases expression | EXP | 12 | 27,677,045 | 27,848,497 | RGD:6480464 | CTD | |
| G | PPIB | peptidylprolyl isomerase B (cyclophilin B) |
|
increases expression | EXP | 15 | 64,448,014 | 64,455,354 | RGD:6480464 | CTD | |
| G | PPIG | peptidylprolyl isomerase G (cyclophilin G) |
|
decreases expression | EXP | 2 | 170,440,850 | 170,494,254 | RGD:6480464 | CTD | |
| G | PPIL2 | peptidylprolyl isomerase (cyclophilin)-like 2 |
|
increases expression | EXP | 22 | 22,020,273 | 22,052,202 | RGD:6480464 | CTD | |
| G | PPL | periplakin |
|
increases expression | EXP | 16 | 4,932,508 | 4,987,136 | RGD:6480464 | CTD | |
| G | PPM1J | protein phosphatase, Mg2+/Mn2+ dependent, 1J |
|
increases expression | EXP | 1 | 113,252,616 | 113,257,950 | RGD:6480464 | CTD | |
| G | PPME1 | protein phosphatase methylesterase 1 |
|
multiple interactions | EXP | 11 | 73,882,368 | 73,965,748 | RGD:6480464 | CTD | |
| G | PPME1 | protein phosphatase methylesterase 1 |
|
increases expression | EXP | 11 | 73,882,368 | 73,965,748 | RGD:6480464 | CTD | |
| G | PPP1CA | protein phosphatase 1, catalytic subunit, alpha isozyme |
|
increases expression | EXP | 11 | 67,165,652 | 67,169,376 | RGD:6480464 | CTD | |
| G | PPP1R10 | protein phosphatase 1, regulatory subunit 10 |
|
multiple interactions | EXP | 6 | 30,568,177 | 30,585,084 | RGD:6480464 | CTD | |
| G | PPP1R10 | protein phosphatase 1, regulatory subunit 10 |
|
increases expression | EXP | 6 | 30,568,177 | 30,585,084 | RGD:6480464 | CTD | |
| G | PPP1R14B | protein phosphatase 1, regulatory (inhibitor) subunit 14B |
|
increases expression | EXP | 11 | 64,011,951 | 64,014,413 | RGD:6480464 | CTD | |
| G | PPP1R9A | protein phosphatase 1, regulatory subunit 9A |
|
multiple interactions | EXP | 7 | 94,536,949 | 94,925,727 | RGD:6480464 | CTD | |
| G | PPP1R9A | protein phosphatase 1, regulatory subunit 9A |
|
decreases expression | EXP | 7 | 94,536,949 | 94,925,727 | RGD:6480464 | CTD | |
| G | PPP2R1A | protein phosphatase 2, regulatory subunit A, alpha |
|
multiple interactions | EXP | 19 | 52,693,055 | 52,729,678 | RGD:6480464 | CTD | |
| G | PPP2R1A | protein phosphatase 2, regulatory subunit A, alpha |
|
increases expression | EXP | 19 | 52,693,055 | 52,729,678 | RGD:6480464 | CTD | |
| G | PPP2R4 | protein phosphatase 2A activator, regulatory subunit 4 |
|
multiple interactions | EXP | 9 | 131,873,228 | 131,911,225 | RGD:6480464 | CTD | |
| G | PPP2R4 | protein phosphatase 2A activator, regulatory subunit 4 |
|
increases expression | EXP | 9 | 131,873,228 | 131,911,225 | RGD:6480464 | CTD | |
| G | PPP2R5D | protein phosphatase 2, regulatory subunit B', delta |
|
increases expression | EXP | 6 | 42,952,237 | 42,980,083 | RGD:6480464 | CTD | |
| G | PPP2R5E | protein phosphatase 2, regulatory subunit B', epsilon isoform |
|
decreases expression | EXP | 14 | 63,841,355 | 64,010,079 | RGD:6480464 | CTD | |
| G | PPP4C | protein phosphatase 4, catalytic subunit |
|
increases expression | EXP | 16 | 30,087,385 | 30,096,695 | RGD:6480464 | CTD | |
| G | PPP6R2 | protein phosphatase 6, regulatory subunit 2 |
|
multiple interactions | EXP | 22 | 50,781,746 | 50,883,519 | RGD:6480464 | CTD | |
| G | PPP6R2 | protein phosphatase 6, regulatory subunit 2 |
|
increases expression | EXP | 22 | 50,781,746 | 50,883,519 | RGD:6480464 | CTD | |
| G | PRAF2 | PRA1 domain family, member 2 |
|
increases expression | EXP | X | 48,928,818 | 48,931,662 | RGD:6480464 | CTD | |
| G | PRDM2 | PR domain containing 2, with ZNF domain |
|
increases expression | EXP | 1 | 14,026,735 | 14,151,574 | RGD:6480464 | CTD | |
| G | PRDX2 | peroxiredoxin 2 |
|
decreases expression | ISO | 19 | 12,907,634 | 12,912,694 | RGD:6480464 | CTD | |
| G | PRKAG1 | protein kinase, AMP-activated, gamma 1 non-catalytic subunit |
|
increases expression | EXP | 12 | 49,396,055 | 49,412,629 | RGD:6480464 | CTD | |
| G | PRKCB | protein kinase C, beta |
|
decreases expression | EXP | 16 | 23,847,300 | 24,231,932 | RGD:6480464 | CTD | |
| G | PRKCI | protein kinase C, iota |
|
multiple interactions | EXP | 3 | 169,940,220 | 170,023,770 | RGD:6480464 | CTD | |
| G | PRKCI | protein kinase C, iota |
|
decreases expression | EXP | 3 | 169,940,220 | 170,023,770 | RGD:6480464 | CTD | |
| G | PRKD2 | protein kinase D2 |
|
increases expression | EXP | 19 | 47,177,573 | 47,220,384 | RGD:6480464 | CTD | |
| G | PRMT1 | protein arginine methyltransferase 1 |
|
multiple interactions | EXP | 19 | 50,180,409 | 50,191,707 | RGD:6480464 | CTD | |
| G | PRMT1 | protein arginine methyltransferase 1 |
|
increases expression | EXP | 19 | 50,180,409 | 50,191,707 | RGD:6480464 | CTD | |
| G | PRMT2 | protein arginine methyltransferase 2 |
|
multiple interactions | EXP | 21 | 48,055,507 | 48,085,155 | RGD:6480464 | CTD | |
| G | PRMT2 | protein arginine methyltransferase 2 |
|
increases expression | EXP | 21 | 48,055,507 | 48,085,155 | RGD:6480464 | CTD | |
| G | PRMT5 | protein arginine methyltransferase 5 |
|
increases expression | EXP | 14 | 23,389,733 | 23,398,661 | RGD:6480464 | CTD | |
| G | PRPF40A | PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae) |
|
decreases expression | EXP | 2 | 153,508,107 | 153,573,975 | RGD:6480464 | CTD | |
| G | PRPF4B | PRP4 pre-mRNA processing factor 4 homolog B (yeast) |
|
decreases expression | EXP | 6 | 4,021,569 | 4,065,217 | RGD:6480464 | CTD | |
| G | PRPF6 | PRP6 pre-mRNA processing factor 6 homolog (S. cerevisiae) |
|
multiple interactions | EXP | 20 | 62,612,431 | 62,664,453 | RGD:6480464 | CTD | |
| G | PRPF6 | PRP6 pre-mRNA processing factor 6 homolog (S. cerevisiae) |
|
increases expression | EXP | 20 | 62,612,431 | 62,664,453 | RGD:6480464 | CTD | |
| G | PRPF8 | PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae) |
|
increases expression | EXP | 17 | 1,553,923 | 1,588,176 | RGD:6480464 | CTD | |
| G | PRRC2C | proline-rich coiled-coil 2C |
|
multiple interactions | EXP | 1 | 171,454,666 | 171,562,650 | RGD:6480464 | CTD | |
| G | PRRC2C | proline-rich coiled-coil 2C |
|
decreases expression | EXP | 1 | 171,454,666 | 171,562,650 | RGD:6480464 | CTD | |
| G | PRSS8 | protease, serine, 8 |
|
increases expression | EXP | 16 | 31,142,754 | 31,147,151 | RGD:6480464 | CTD | |
| G | PRUNE | prune exopolyphosphatase |
|
multiple interactions | EXP | 1 | 150,980,973 | 151,008,189 | RGD:6480464 | CTD | |
| G | PRX | periaxin |
|
increases expression | EXP | 19 | 40,899,671 | 40,919,271 | RGD:6480464 | CTD | |
| G | PSAP | prosaposin |
|
increases expression | EXP | 10 | 73,576,055 | 73,611,082 | RGD:6480464 | CTD | |
| G | PSIP1 | PC4 and SFRS1 interacting protein 1 |
|
decreases expression | EXP | 9 | 15,464,064 | 15,511,003 | RGD:6480464 | CTD | |
| G | PSMB10 | proteasome (prosome, macropain) subunit, beta type, 10 |
|
increases expression | EXP | 16 | 67,968,407 | 67,970,780 | RGD:6480464 | CTD | |
| G | PSMB4 | proteasome (prosome, macropain) subunit, beta type, 4 |
|
increases expression | EXP | 1 | 151,372,041 | 151,374,412 | RGD:6480464 | CTD | |
| G | PSMC1 | proteasome (prosome, macropain) 26S subunit, ATPase, 1 |
|
increases expression | EXP | 14 | 90,722,894 | 90,738,966 | RGD:6480464 | CTD | |
| G | PSMC4 | proteasome (prosome, macropain) 26S subunit, ATPase, 4 |
|
increases expression | EXP | 19 | 40,476,912 | 40,487,671 | RGD:6480464 | CTD | |
| G | PSMD4 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 |
|
increases expression | EXP | 1 | 151,227,197 | 151,239,955 | RGD:6480464 | CTD | |
| G | PSMD6 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 |
|
increases expression | EXP | 3 | 63,996,231 | 64,009,120 | RGD:6480464 | CTD | |
| G | PSMD8 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 |
|
increases expression | EXP | 19 | 38,865,190 | 38,874,464 | RGD:6480464 | CTD | |
| G | PSME1 | proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
|
increases expression | EXP | 14 | 24,605,378 | 24,608,176 | RGD:6480464 | CTD | |
| G | PTGDS | prostaglandin D2 synthase 21kDa (brain) |
|
increases expression | EXP | 9 | 139,871,956 | 139,876,194 | RGD:6480464 | CTD | |
| G | PTGES | prostaglandin E synthase |
|
multiple interactions | EXP | 9 | 132,500,615 | 132,515,344 | RGD:6480464 | CTD | |
| G | PTGES | prostaglandin E synthase |
|
increases expression | EXP | 9 | 132,500,615 | 132,515,344 | RGD:6480464 | CTD | |
| G | PTGR1 | prostaglandin reductase 1 |
|
affects expression | ISO | 9 | 114,312,002 | 114,362,135 | RGD:6480464 | CTD | |
| G | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions | ISO | 1 | 186,640,944 | 186,649,559 | RGD:6480464 | CTD | |
| G | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions | ISO | 1 | 186,640,944 | 186,649,559 | RGD:6480464 | CTD | |
| G | PTMS | parathymosin |
|
increases expression | EXP | 12 | 6,875,541 | 6,880,118 | RGD:6480464 | CTD | |
| G | PTOV1 | prostate tumor overexpressed 1 |
|
increases expression | EXP | 19 | 50,354,416 | 50,363,999 | RGD:6480464 | CTD | |
| G | PTPN1 | protein tyrosine phosphatase, non-receptor type 1 |
|
increases expression | ISO | 20 | 49,126,891 | 49,201,088 | RGD:6480464 | CTD | |
| G | PTPN1 | protein tyrosine phosphatase, non-receptor type 1 |
|
decreases glutathionylation | ISO | 20 | 49,126,891 | 49,201,088 | RGD:6480464 | CTD | |
| G | PTPN18 | protein tyrosine phosphatase, non-receptor type 18 (brain-derived) |
|
increases expression | EXP | 2 | 131,113,580 | 131,132,982 | RGD:6480464 | CTD | |
| G | PTPN6 | protein tyrosine phosphatase, non-receptor type 6 |
|
multiple interactions | EXP | 12 | 7,055,740 | 7,070,479 | RGD:6480464 | CTD | |
| G | PTPN6 | protein tyrosine phosphatase, non-receptor type 6 |
|
increases expression | EXP | 12 | 7,055,740 | 7,070,479 | RGD:6480464 | CTD | |
| G | PTPRO | protein tyrosine phosphatase, receptor type, O |
|
decreases expression | EXP | 12 | 15,475,191 | 15,751,265 | RGD:6480464 | CTD | |
| G | PTRF | polymerase I and transcript release factor |
|
increases expression | EXP | 17 | 40,554,467 | 40,575,338 | RGD:6480464 | CTD | |
| G | PTX3 | pentraxin 3, long |
|
increases expression | EXP | 3 | 157,154,580 | 157,161,417 | RGD:6480464 | CTD | |
| G | PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) |
|
increases expression | EXP | 19 | 45,349,393 | 45,392,485 | RGD:6480464 | CTD | |
| G | PWP1 | PWP1 homolog (S. cerevisiae) |
|
multiple interactions | EXP | 12 | 108,079,590 | 108,106,257 | RGD:6480464 | CTD | |
| G | PWP1 | PWP1 homolog (S. cerevisiae) |
|
decreases expression | EXP | 12 | 108,079,590 | 108,106,257 | RGD:6480464 | CTD | |
| G | PYCARD | PYD and CARD domain containing |
|
increases expression | EXP | 16 | 31,212,807 | 31,214,097 | RGD:6480464 | CTD | |
| G | PYCRL | pyrroline-5-carboxylate reductase-like |
|
multiple interactions | EXP | 8 | 144,686,083 | 144,691,784 | RGD:6480464 | CTD | |
| G | PYGB | phosphorylase, glycogen; brain |
|
increases expression | EXP | 20 | 25,228,706 | 25,278,648 | RGD:6480464 | CTD | |
| G | QTRT1 | queuine tRNA-ribosyltransferase 1 |
|
increases expression | EXP | 19 | 10,812,112 | 10,824,043 | RGD:6480464 | CTD | |
| G | QTRT1 | queuine tRNA-ribosyltransferase 1 |
|
multiple interactions | EXP | 19 | 10,812,112 | 10,824,043 | RGD:6480464 | CTD | |
| G | R3HDM1 | R3H domain containing 1 |
|
decreases expression | EXP | 2 | 136,289,083 | 136,482,839 | RGD:6480464 | CTD | |
| G | RAB11B | RAB11B, member RAS oncogene family |
|
increases expression | EXP | 19 | 8,455,205 | 8,469,318 | RGD:6480464 | CTD | |
| G | RAB14 | RAB14, member RAS oncogene family |
|
decreases expression | EXP | 9 | 123,940,415 | 123,964,365 | RGD:6480464 | CTD | |
| G | RAB25 | RAB25, member RAS oncogene family |
|
increases expression | EXP | 1 | 156,030,966 | 156,040,295 | RGD:6480464 | CTD | |
| G | RABAC1 | Rab acceptor 1 (prenylated) |
|
increases expression | EXP | 19 | 42,460,833 | 42,463,528 | RGD:6480464 | CTD | |
| G | RABGAP1 | RAB GTPase activating protein 1 |
|
decreases expression | EXP | 9 | 125,703,288 | 125,867,147 | RGD:6480464 | CTD | |
| G | RAD23A | RAD23 homolog A (S. cerevisiae) |
|
increases expression | EXP | 19 | 13,056,628 | 13,064,457 | RGD:6480464 | CTD | |
| G | RAD23B | RAD23 homolog B (S. cerevisiae) |
|
decreases expression | EXP | 9 | 110,045,517 | 110,094,475 | RGD:6480464 | CTD | |
| G | RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 |
|
multiple interactions | EXP | 3 | 12,625,100 | 12,705,700 | RGD:6480464 | CTD | |
| G | RALBP1 | ralA binding protein 1 |
|
decreases expression | EXP | 18 | 9,475,530 | 9,538,106 | RGD:6480464 | CTD | |
| G | RALBP1 | ralA binding protein 1 |
|
multiple interactions | EXP | 18 | 9,475,530 | 9,538,106 | RGD:6480464 | CTD | |
| G | RALGPS1 | Ral GEF with PH domain and SH3 binding motif 1 |
|
decreases expression | EXP | 9 | 129,677,053 | 129,985,445 | RGD:6480464 | CTD | |
| G | RALY | RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog (mouse)) |
|
increases expression | EXP | 20 | 32,581,458 | 32,670,991 | RGD:6480464 | CTD | |
| G | RANBP2 | RAN binding protein 2 |
|
multiple interactions | EXP | 2 | 109,335,937 | 109,402,267 | RGD:6480464 | CTD | |
| G | RANBP2 | RAN binding protein 2 |
|
decreases expression | EXP | 2 | 109,335,937 | 109,402,267 | RGD:6480464 | CTD | |
| G | RANBP3 | RAN binding protein 3 |
|
increases expression | EXP | 19 | 5,916,150 | 5,978,320 | RGD:6480464 | CTD | |
| G | RANBP9 | RAN binding protein 9 |
|
decreases expression | EXP | 6 | 13,621,730 | 13,711,796 | RGD:6480464 | CTD | |
| G | RANGAP1 | Ran GTPase activating protein 1 |
|
multiple interactions | EXP | 22 | 41,641,615 | 41,682,216 | RGD:6480464 | CTD | |
| G | RANGAP1 | Ran GTPase activating protein 1 |
|
increases expression | EXP | 22 | 41,641,615 | 41,682,216 | RGD:6480464 | CTD | |
| G | RAPGEF6 | Rap guanine nucleotide exchange factor (GEF) 6 |
|
decreases expression | EXP | 5 | 130,759,614 | 130,970,929 | RGD:6480464 | CTD | |
| G | RASSF1 | Ras association (RalGDS/AF-6) domain family member 1 |
|
increases expression | EXP | 3 | 50,367,217 | 50,378,367 | RGD:6480464 | CTD | |
| G | RASSF7 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
|
multiple interactions | EXP | 11 | 560,971 | 564,025 | RGD:6480464 | CTD | |
| G | RBBP4 | retinoblastoma binding protein 4 |
|
multiple interactions | EXP | 1 | 33,116,749 | 33,151,812 | RGD:6480464 | CTD | |
| G | RBBP6 | retinoblastoma binding protein 6 |
|
decreases expression | EXP | 16 | 24,550,908 | 24,584,184 | RGD:6480464 | CTD | |
| G | RBBP6 | retinoblastoma binding protein 6 |
|
multiple interactions | EXP | 16 | 24,550,908 | 24,584,184 | RGD:6480464 | CTD | |
| G | RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 |
|
increases expression | EXP | 20 | 388,709 | 411,610 | RGD:6480464 | CTD | |
| G | RBM10 | RNA binding motif protein 10 |
|
increases expression | EXP | X | 47,004,617 | 47,046,214 | RGD:6480464 | CTD | |
| G | RBM14 | RNA binding motif protein 14 |
|
increases expression | EXP | 11 | 66,384,053 | 66,397,405 | RGD:6480464 | CTD | |
| G | RBM25 | RNA binding motif protein 25 |
|
multiple interactions | EXP | 14 | 73,525,221 | 73,588,076 | RGD:6480464 | CTD | |
| G | RBM25 | RNA binding motif protein 25 |
|
decreases expression | EXP | 14 | 73,525,221 | 73,588,076 | RGD:6480464 | CTD | |
| G | RBM4 | RNA binding motif protein 4 |
|
decreases expression | EXP | 11 | 66,406,088 | 66,435,856 | RGD:6480464 | CTD | |
| G | RBM42 | RNA binding motif protein 42 |
|
increases expression | EXP | 19 | 36,119,980 | 36,128,587 | RGD:6480464 | CTD | |
| G | RBM5 | RNA binding motif protein 5 |
|
increases expression | EXP | 3 | 50,126,341 | 50,156,397 | RGD:6480464 | CTD | |
| G | RBMS1 | RNA binding motif, single stranded interacting protein 1 |
|
decreases expression | EXP | 2 | 161,128,662 | 161,350,318 | RGD:6480464 | CTD | |
| G | RBMS1 | RNA binding motif, single stranded interacting protein 1 |
|
increases expression | EXP | 2 | 161,128,662 | 161,350,318 | RGD:6480464 | CTD | |
| G | RBPMS | RNA binding protein with multiple splicing |
|
increases expression | EXP | 8 | 30,241,944 | 30,429,734 | RGD:6480464 | CTD | |
| G | RCHY1 | ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase |
|
decreases expression | EXP | 4 | 76,404,247 | 76,439,640 | RGD:6480464 | CTD | |
| G | RCOR3 | REST corepressor 3 |
|
decreases expression | EXP | 1 | 211,432,708 | 211,489,727 | RGD:6480464 | CTD | |
| G | RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) |
|
decreases expression | EXP | 14 | 68,143,517 | 68,162,510 | RGD:6480464 | CTD | |
| G | RECK | reversion-inducing-cysteine-rich protein with kazal motifs |
|
decreases expression | EXP | 9 | 36,036,910 | 36,124,452 | RGD:6480464 | CTD | |
| G | RECQL | RecQ protein-like (DNA helicase Q1-like) |
|
multiple interactions | EXP | 12 | 21,621,844 | 21,654,603 | RGD:6480464 | CTD | |
| G | RECQL | RecQ protein-like (DNA helicase Q1-like) |
|
decreases expression | EXP | 12 | 21,621,844 | 21,654,603 | RGD:6480464 | CTD | |
| G | RECQL5 | RecQ protein-like 5 |
|
increases expression | EXP | 17 | 73,622,925 | 73,663,269 | RGD:6480464 | CTD | |
| G | RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions | ISO | 11 | 65,421,067 | 65,430,443 | RGD:6480464 | CTD | |
| G | RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression | EXP | 11 | 65,421,067 | 65,430,443 | RGD:6480464 | CTD | |
| G | RERG | RAS-like, estrogen-regulated, growth inhibitor |
|
increases expression | EXP | 12 | 15,260,716 | 15,374,411 | RGD:6480464 | CTD | |
| G | RFTN1 | raftlin, lipid raft linker 1 |
|
increases expression | EXP | 3 | 16,357,352 | 16,555,222 | RGD:6480464 | CTD | |
| G | RGPD8 | RANBP2-like and GRIP domain containing 8 |
|
multiple interactions | EXP | 2 | 113,125,946 | 113,191,222 | RGD:6480464 | CTD | |
| G | RGPD8 | RANBP2-like and GRIP domain containing 8 |
|
decreases expression | EXP | 2 | 113,125,946 | 113,191,222 | RGD:6480464 | CTD | |
| G | RGS13 | regulator of G-protein signaling 13 |
|
increases expression | EXP | 1 | 192,605,268 | 192,629,441 | RGD:6480464 | CTD | |
| G | RHBDD3 | rhomboid domain containing 3 |
|
increases expression | EXP | 22 | 29,655,844 | 29,663,914 | RGD:6480464 | CTD | |
| G | RHOBTB1 | Rho-related BTB domain containing 1 |
|
multiple interactions | EXP | 10 | 62,629,196 | 62,761,198 | RGD:6480464 | CTD | |
| G | RHOBTB1 | Rho-related BTB domain containing 1 |
|
decreases expression | EXP | 10 | 62,629,196 | 62,761,198 | RGD:6480464 | CTD | |
| G | RHOBTB3 | Rho-related BTB domain containing 3 |
|
multiple interactions | EXP | 5 | 95,066,850 | 95,132,071 | RGD:6480464 | CTD | |
| G | RHOBTB3 | Rho-related BTB domain containing 3 |
|
decreases expression | EXP | 5 | 95,066,850 | 95,132,071 | RGD:6480464 | CTD | |
| G | RHOG | ras homolog family member G |
|
increases expression | EXP | 11 | 3,848,208 | 3,862,213 | RGD:6480464 | CTD | |
| G | RHOU | ras homolog family member U |
|
increases expression | EXP | 1 | 228,780,394 | 228,882,416 | RGD:6480464 | CTD | |
| G | RING1 | ring finger protein 1 |
|
increases expression | EXP | 6 | 33,176,286 | 33,180,499 | RGD:6480464 | CTD | |
| G | RNASEH1 | ribonuclease H1 |
|
decreases expression | EXP | 2 | 3,592,678 | 3,605,940 | RGD:6480464 | CTD | |
| G | RND1 | Rho family GTPase 1 |
|
increases expression | EXP | 12 | 49,250,916 | 49,259,653 | RGD:6480464 | CTD | |
| G | RND3 | Rho family GTPase 3 |
|
decreases expression | EXP | 2 | 151,324,707 | 151,344,209 | RGD:6480464 | CTD | |
| G | RNF111 | ring finger protein 111 |
|
decreases expression | EXP | 15 | 59,279,865 | 59,389,618 | RGD:6480464 | CTD | |
| G | RNF114 | ring finger protein 114 |
|
increases expression | EXP | 20 | 48,552,914 | 48,570,422 | RGD:6480464 | CTD | |
| G | RNF220 | ring finger protein 220 |
|
increases expression | EXP | 1 | 44,870,960 | 45,117,396 | RGD:6480464 | CTD | |
| G | RNF40 | ring finger protein 40, E3 ubiquitin protein ligase |
|
increases expression | EXP | 16 | 30,772,933 | 30,787,628 | RGD:6480464 | CTD | |
| G | RNH1 | ribonuclease/angiogenin inhibitor 1 |
|
increases expression | EXP | 11 | 494,512 | 507,283 | RGD:6480464 | CTD | |
| G | RNPEP | arginyl aminopeptidase (aminopeptidase B) |
|
increases expression | EXP | 1 | 201,951,766 | 201,975,275 | RGD:6480464 | CTD | |
| G | RNPS1 | RNA binding protein S1, serine-rich domain |
|
increases expression | EXP | 16 | 2,303,100 | 2,318,413 | RGD:6480464 | CTD | |
| G | RPL10A | ribosomal protein L10a |
|
decreases expression | EXP | 6 | 35,436,178 | 35,438,558 | RGD:6480464 | CTD | |
| G | RPL14 | ribosomal protein L14 |
|
decreases expression | EXP | 3 | 40,498,783 | 40,503,863 | RGD:6480464 | CTD | |
| G | RPL23 | ribosomal protein L23 |
|
decreases expression | EXP | 17 | 37,006,321 | 37,010,053 | RGD:6480464 | CTD | |
| G | RPL27 | ribosomal protein L27 |
|
decreases expression | EXP | 17 | 41,150,446 | 41,154,976 | RGD:6480464 | CTD | |
| G | RPL31 | ribosomal protein L31 |
|
decreases expression | EXP | 2 | 101,618,691 | 101,636,155 | RGD:6480464 | CTD | |
| G | RPL37A | ribosomal protein L37a |
|
decreases expression | EXP | 2 | 217,363,520 | 217,366,190 | RGD:6480464 | CTD | |
| G | RPL38 | ribosomal protein L38 |
|
decreases expression | EXP | 17 | 72,199,795 | 72,206,019 | RGD:6480464 | CTD | |
| G | RPL39 | ribosomal protein L39 |
|
decreases expression | EXP | X X |
118,920,469 118,923,864 |
118,925,606 118,923,974 |
RGD:6480464 | CTD | |
| G | RPL7 | ribosomal protein L7 |
|
decreases expression | EXP | 8 | 74,202,874 | 74,205,869 | RGD:6480464 | CTD | |
| G | RPRD2 | regulation of nuclear pre-mRNA domain containing 2 |
|
increases expression | EXP | 1 | 150,336,990 | 150,449,042 | RGD:6480464 | CTD | |
| G | RPS20 | ribosomal protein S20 |
|
decreases expression | EXP | 8 | 56,980,739 | 56,987,140 | RGD:6480464 | CTD | |
| G | RPS21 | ribosomal protein S21 |
|
decreases expression | EXP | 20 | 60,962,121 | 60,963,576 | RGD:6480464 | CTD | |
| G | RPS25 | ribosomal protein S25 |
|
decreases expression | EXP | 11 | 118,886,422 | 118,889,057 | RGD:6480464 | CTD | |
| G | RPS27 | ribosomal protein S27 |
|
decreases expression | EXP | 1 | 153,963,239 | 153,964,631 | RGD:6480464 | CTD | |
| G | RPS27L | ribosomal protein S27-like |
|
decreases expression | EXP | 15 | 63,445,539 | 63,449,741 | RGD:6480464 | CTD | |
| G | RPS29 | ribosomal protein S29 |
|
decreases expression | EXP | 14 | 50,044,039 | 50,053,094 | RGD:6480464 | CTD | |
| G | RPS4Y1 | ribosomal protein S4, Y-linked 1 |
|
increases expression | EXP | Y | 2,709,623 | 2,734,997 | RGD:6480464 | CTD | |
| G | RPS6KA1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
|
multiple interactions | EXP | 1 | 26,856,249 | 26,901,520 | RGD:6480464 | CTD | |
| G | RPS6KA1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
|
increases expression | EXP | 1 | 26,856,249 | 26,901,520 | RGD:6480464 | CTD | |
| G | RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
|
multiple interactions | EXP | 6 | 166,822,854 | 167,275,771 | RGD:6480464 | CTD | |
| G | RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
|
increases expression | EXP | 6 | 166,822,854 | 167,275,771 | RGD:6480464 | CTD | |
| G | RPS7 | ribosomal protein S7 |
|
decreases expression | EXP | 2 | 3,622,853 | 3,628,509 | RGD:6480464 | CTD | |
| G | RRBP1 | ribosome binding protein 1 |
|
multiple interactions | EXP | 20 | 17,594,323 | 17,662,928 | RGD:6480464 | CTD | |
| G | RRP1 | ribosomal RNA processing 1 homolog (S. cerevisiae) |
|
multiple interactions | EXP | 21 | 45,209,418 | 45,223,983 | RGD:6480464 | CTD | |
| G | RRP1 | ribosomal RNA processing 1 homolog (S. cerevisiae) |
|
increases expression | EXP | 21 | 45,209,418 | 45,223,983 | RGD:6480464 | CTD | |
| G | RRP7A | ribosomal RNA processing 7 homolog A (S. cerevisiae) |
|
increases expression | EXP | 22 | 42,904,341 | 42,915,829 | RGD:6480464 | CTD | |
| G | RSAD1 | radical S-adenosyl methionine domain containing 1 |
|
increases expression | EXP | 17 | 48,556,190 | 48,563,336 | RGD:6480464 | CTD | |
| G | RSRC2 | arginine/serine-rich coiled-coil 2 |
|
multiple interactions | EXP | 12 | 122,989,190 | 123,011,560 | RGD:6480464 | CTD | |
| G | RSRC2 | arginine/serine-rich coiled-coil 2 |
|
decreases expression | EXP | 12 | 122,989,190 | 123,011,560 | RGD:6480464 | CTD | |
| G | RUFY3 | RUN and FYVE domain containing 3 |
|
decreases expression | EXP | 4 | 71,570,654 | 71,674,336 | RGD:6480464 | CTD | |
| G | RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
|
multiple interactions | EXP | 8 | 92,967,195 | 93,115,454 | RGD:6480464 | CTD | |
| G | RUNX3 | runt-related transcription factor 3 |
|
increases expression | EXP | 1 | 25,226,002 | 25,291,501 | RGD:6480464 | CTD | |
| G | RUSC2 | RUN and SH3 domain containing 2 |
|
increases expression | EXP | 9 | 35,490,007 | 35,561,895 | RGD:6480464 | CTD | |
| G | RUVBL1 | RuvB-like 1 (E. coli) |
|
increases expression | EXP | 3 | 127,799,800 | 127,842,671 | RGD:6480464 | CTD | |
| G | RUVBL2 | RuvB-like 2 (E. coli) |
|
increases expression | EXP | 19 | 49,497,156 | 49,519,182 | RGD:6480464 | CTD | |
| G | RXRA | retinoid X receptor, alpha |
|
increases expression | EXP | 9 | 137,218,316 | 137,332,431 | RGD:6480464 | CTD | |
| G | RYBP | RING1 and YY1 binding protein |
|
multiple interactions | EXP | 3 | 72,423,744 | 72,495,774 | RGD:6480464 | CTD | |
| G | RYBP | RING1 and YY1 binding protein |
|
decreases expression | EXP | 3 | 72,423,744 | 72,495,774 | RGD:6480464 | CTD | |
| G | S100A11 | S100 calcium binding protein A11 |
|
increases expression | EXP | 1 | 152,004,982 | 152,009,511 | RGD:6480464 | CTD | |
| G | S100A6 | S100 calcium binding protein A6 |
|
increases expression | EXP | 1 | 153,507,076 | 153,508,717 | RGD:6480464 | CTD | |
| G | SACS | spastic ataxia of Charlevoix-Saguenay (sacsin) |
|
decreases expression | EXP | 13 | 23,902,965 | 24,007,841 | RGD:6480464 | CTD | |
| G | SAFB | scaffold attachment factor B |
|
increases expression | EXP | 19 | 5,623,046 | 5,668,489 | RGD:6480464 | CTD | |
| G | SAFB2 | scaffold attachment factor B2 |
|
increases expression | EXP | 19 | 5,587,010 | 5,622,938 | RGD:6480464 | CTD | |
| G | SAMM50 | sorting and assembly machinery component 50 homolog (S. cerevisiae) |
|
multiple interactions | EXP | 22 | 44,351,261 | 44,392,412 | RGD:6480464 | CTD | |
| G | SARDH | sarcosine dehydrogenase |
|
increases expression | EXP | 9 | 136,528,682 | 136,605,077 | RGD:6480464 | CTD | |
| G | SART1 | squamous cell carcinoma antigen recognized by T cells |
|
increases expression | EXP | 11 | 65,729,160 | 65,747,607 | RGD:6480464 | CTD | |
| G | SART3 | squamous cell carcinoma antigen recognized by T cells 3 |
|
multiple interactions | EXP | 12 | 108,915,991 | 108,955,165 | RGD:6480464 | CTD | |
| G | SATB1 | SATB homeobox 1 |
|
decreases expression | EXP | 3 | 18,389,133 | 18,480,265 | RGD:6480464 | CTD | |
| G | SCAF11 | SR-related CTD-associated factor 11 |
|
multiple interactions | EXP | 12 | 46,312,914 | 46,384,401 | RGD:6480464 | CTD | |
| G | SCAF4 | SR-related CTD-associated factor 4 |
|
decreases expression | EXP | 21 | 33,043,313 | 33,104,431 | RGD:6480464 | CTD | |
| G | SCAMP1 | secretory carrier membrane protein 1 |
|
decreases expression | EXP | 5 | 77,656,339 | 77,776,562 | RGD:6480464 | CTD | |
| G | SCAMP3 | secretory carrier membrane protein 3 |
|
multiple interactions | EXP | 1 | 155,225,770 | 155,232,176 | RGD:6480464 | CTD | |
| G | SCAMP3 | secretory carrier membrane protein 3 |
|
increases expression | EXP | 1 | 155,225,770 | 155,232,176 | RGD:6480464 | CTD | |
| G | SCAPER | S-phase cyclin A-associated protein in the ER |
|
decreases expression | EXP | 15 | 76,640,526 | 77,176,217 | RGD:6480464 | CTD | |
| G | SCAPER | S-phase cyclin A-associated protein in the ER |
|
multiple interactions | EXP | 15 | 76,640,526 | 77,176,217 | RGD:6480464 | CTD | |
| G | SCARA5 | scavenger receptor class A, member 5 (putative) |
|
increases expression | EXP | 8 | 27,727,399 | 27,850,369 | RGD:6480464 | CTD | |
| G | SCML1 | sex comb on midleg-like 1 (Drosophila) |
|
multiple interactions | EXP | X | 17,755,592 | 17,773,105 | RGD:6480464 | CTD | |
| G | SCML1 | sex comb on midleg-like 1 (Drosophila) |
|
decreases expression | EXP | X | 17,755,592 | 17,773,105 | RGD:6480464 | CTD | |
| G | SCML2 | sex comb on midleg-like 2 (Drosophila) |
|
decreases expression | EXP | X | 18,257,433 | 18,372,844 | RGD:6480464 | CTD | |
| G | SCN9A | sodium channel, voltage-gated, type IX, alpha subunit |
|
increases expression | EXP | 2 | 167,051,695 | 167,232,497 | RGD:6480464 | CTD | |
| G | SCO2 | SCO2 cytochrome c oxidase assembly protein |
|
increases expression | EXP | 22 | 50,961,997 | 50,964,868 | RGD:6480464 | CTD | |
| G | SCRG1 | stimulator of chondrogenesis 1 |
|
decreases expression | EXP | 4 | 174,309,299 | 174,320,617 | RGD:6480464 | CTD | |
| G | SDC3 | syndecan 3 |
|
increases expression | EXP | 1 | 31,342,313 | 31,381,480 | RGD:6480464 | CTD | |
| G | SDCCAG8 | serologically defined colon cancer antigen 8 |
|
decreases expression | EXP | 1 | 243,419,307 | 243,663,393 | RGD:6480464 | CTD | |
| G | SDCCAG8 | serologically defined colon cancer antigen 8 |
|
multiple interactions | EXP | 1 | 243,419,307 | 243,663,393 | RGD:6480464 | CTD | |
| G | SDK1 | sidekick cell adhesion molecule 1 |
|
increases expression | EXP | 7 | 3,341,080 | 4,308,632 | RGD:6480464 | CTD | |
| G | SEC13 | SEC13 homolog (S. cerevisiae) |
|
increases expression | EXP | 3 | 10,342,615 | 10,362,858 | RGD:6480464 | CTD | |
| G | SEC16A | SEC16 homolog A (S. cerevisiae) |
|
decreases expression | EXP | 9 | 139,334,548 | 139,377,507 | RGD:6480464 | CTD | |
| G | SEC22B | SEC22 vesicle trafficking protein homolog B (S. cerevisiae) (gene/pseudogene) |
|
decreases expression | EXP | 1 | 145,096,407 | 145,116,922 | RGD:6480464 | CTD | |
| G | SEC23B | Sec23 homolog B (S. cerevisiae) |
|
increases expression | EXP | 20 | 18,488,188 | 18,542,059 | RGD:6480464 | CTD | |
| G | SEC24B | SEC24 family, member B (S. cerevisiae) |
|
decreases expression | EXP | 4 | 110,354,971 | 110,461,615 | RGD:6480464 | CTD | |
| G | SEC31A | SEC31 homolog A (S. cerevisiae) |
|
multiple interactions | EXP | 4 | 83,739,814 | 83,812,419 | RGD:6480464 | CTD | |
| G | SEC62 | SEC62 homolog (S. cerevisiae) |
|
decreases expression | EXP | 3 | 169,684,580 | 169,716,161 | RGD:6480464 | CTD | |
| G | SEC62 | SEC62 homolog (S. cerevisiae) |
|
multiple interactions | EXP | 3 | 169,684,580 | 169,716,161 | RGD:6480464 | CTD | |
| G | SECISBP2L | SECIS binding protein 2-like |
|
multiple interactions | EXP | 15 | 49,280,835 | 49,338,760 | RGD:6480464 | CTD | |
| G | SECISBP2L | SECIS binding protein 2-like |
|
decreases expression | EXP | 15 | 49,280,835 | 49,338,760 | RGD:6480464 | CTD | |
| G | SELENBP1 | selenium binding protein 1 |
|
increases expression | EXP | 1 | 151,336,778 | 151,345,210 | RGD:6480464 | CTD | |
| G | SELK | selenoprotein K |
|
affects expression | ISO | 3 | 53,919,226 | 53,925,989 | RGD:6480464 | CTD | |
| G | SEMA3B | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
|
increases expression | EXP | 3 | 50,305,040 | 50,314,573 | RGD:6480464 | CTD | |
| G | SEP15 | 15 kDa selenoprotein |
|
decreases expression | ISO | 1 | 87,328,128 | 87,380,107 | RGD:6480464 | CTD | |
| G | SEP15 | 15 kDa selenoprotein |
|
decreases response to substance | EXP | 1 | 87,328,128 | 87,380,107 | RGD:6480464 | CTD | |
| G | SEPHS2 | selenophosphate synthetase 2 |
|
affects expression | ISO | 16 | 30,454,952 | 30,457,224 | RGD:6480464 | CTD | |
| G | SEPP1 | selenoprotein P, plasma, 1 |
|
multiple interactions | EXP | 5 | 42,799,982 | 42,812,024 | RGD:6480464 | CTD | |
| G | SEPP1 | selenoprotein P, plasma, 1 |
|
decreases expression | EXP | 5 | 42,799,982 | 42,812,024 | RGD:6480464 | CTD | |
| G | SEPP1 | selenoprotein P, plasma, 1 |
|
affects expression | ISO | 5 | 42,799,982 | 42,812,024 | RGD:6480464 | CTD | |
| G | SEPP1 | selenoprotein P, plasma, 1 |
|
affects abundance | ISO | 5 | 42,799,982 | 42,812,024 | RGD:6480464 | CTD | |
| G | SEPP1 | selenoprotein P, plasma, 1 |
|
affects response to substance | EXP | 5 | 42,799,982 | 42,812,024 | RGD:6480464 | CTD | |
| G | SEPP1 | selenoprotein P, plasma, 1 |
|
affects response to substance | ISO | 5 | 42,799,982 | 42,812,024 | RGD:6480464 | CTD | |
| G | SEPP1 | selenoprotein P, plasma, 1 |
|
multiple interactions | ISO | 5 | 42,799,982 | 42,812,024 | RGD:6480464 | CTD | |
| G | SEPP1 | selenoprotein P, plasma, 1 |
|
affects expression | ISO | 5 | 42,799,982 | 42,812,024 | RGD:6480464 | CTD | |
| G | SEPP1 | selenoprotein P, plasma, 1 |
|
increases transport | ISO | 5 | 42,799,982 | 42,812,024 | RGD:6480464 | CTD | |
| G | SEPP1 | selenoprotein P, plasma, 1 |
|
decreases expression | ISO | 5 | 42,799,982 | 42,812,024 | RGD:6480464 | CTD | |
| G | SEPT7 | septin 7 |
|
increases expression | EXP | 7 | 35,840,596 | 35,946,715 | RGD:6480464 | CTD | |
| G | SEPW1 | selenoprotein W, 1 |
|
decreases expression | EXP | 19 | 48,281,842 | 48,287,939 | RGD:6480464 | CTD | |
| G | SEPW1 | selenoprotein W, 1 |
|
increases expression | EXP | 19 | 48,281,842 | 48,287,939 | RGD:6480464 | CTD | |
| G | SEPW1 | selenoprotein W, 1 |
|
affects expression | ISO | 19 | 48,281,842 | 48,287,939 | RGD:6480464 | CTD | |
| G | SEPW1 | selenoprotein W, 1 |
|
decreases expression | ISO | 19 | 48,281,842 | 48,287,939 | RGD:6480464 | CTD | |
| G | SEPW1 | selenoprotein W, 1 |
|
affects expression | ISO | 19 | 48,281,842 | 48,287,939 | RGD:6480464 | CTD | |
| G | SEPW1 | selenoprotein W, 1 |
|
affects expression | ISO | 19 | 48,281,842 | 48,287,939 | RGD:6480464 | CTD | |
| G | SEPW1 | selenoprotein W, 1 |
|
decreases expression | ISO | 19 | 48,281,842 | 48,287,939 | RGD:6480464 | CTD | |
| G | SEPW1 | selenoprotein W, 1 |
|
increases degradation | ISO | 19 | 48,281,842 | 48,287,939 | RGD:6480464 | CTD | |
| G | SERBP1 | SERPINE1 mRNA binding protein 1 |
|
decreases expression | EXP | 1 | 67,873,493 | 67,896,123 | RGD:6480464 | CTD | |
| G | SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
|
multiple interactions | ISO | 14 | 95,078,714 | 95,090,390 | RGD:6480464 | CTD | |
| G | SERPINF1 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
|
increases expression | EXP | 17 | 1,665,259 | 1,680,859 | RGD:6480464 | CTD | |
| G | SERTAD2 | SERTA domain containing 2 |
|
decreases expression | EXP | 2 | 64,858,755 | 64,881,046 | RGD:6480464 | CTD | |
| G | SET | SET nuclear oncogene |
|
multiple interactions | EXP | 9 | 131,445,934 | 131,458,675 | RGD:6480464 | CTD | |
| G | SETBP1 | SET binding protein 1 |
|
decreases expression | EXP | 18 | 42,260,138 | 42,648,475 | RGD:6480464 | CTD | |
| G | SETD6 | SET domain containing 6 |
|
multiple interactions | EXP | 16 | 58,549,383 | 58,554,431 | RGD:6480464 | CTD | |
| G | SETD6 | SET domain containing 6 |
|
decreases expression | EXP | 16 | 58,549,383 | 58,554,431 | RGD:6480464 | CTD | |
| G | SETMAR | SET domain and mariner transposase fusion gene |
|
decreases expression | EXP | 3 | 4,344,988 | 4,358,949 | RGD:6480464 | CTD | |
| G | SF1 | splicing factor 1 |
|
multiple interactions | EXP | 11 | 64,532,076 | 64,546,316 | RGD:6480464 | CTD | |
| G | SF1 | splicing factor 1 |
|
decreases expression | EXP | 11 | 64,532,076 | 64,546,316 | RGD:6480464 | CTD | |
| G | SF3A2 | splicing factor 3a, subunit 2, 66kDa |
|
increases expression | EXP | 19 | 2,236,816 | 2,248,678 | RGD:6480464 | CTD | |
| G | SF3A2 | splicing factor 3a, subunit 2, 66kDa |
|
multiple interactions | EXP | 19 | 2,236,816 | 2,248,678 | RGD:6480464 | CTD | |
| G | SF3B1 | splicing factor 3b, subunit 1, 155kDa |
|
multiple interactions | EXP | 2 | 198,256,698 | 198,299,771 | RGD:6480464 | CTD | |
| G | SF3B1 | splicing factor 3b, subunit 1, 155kDa |
|
decreases expression | EXP | 2 | 198,256,698 | 198,299,771 | RGD:6480464 | CTD | |
| G | SF3B4 | splicing factor 3b, subunit 4, 49kDa |
|
increases expression | EXP | 1 | 149,895,209 | 149,900,144 | RGD:6480464 | CTD | |
| G | SGSH | N-sulfoglucosamine sulfohydrolase |
|
increases expression | EXP | 17 | 78,183,079 | 78,194,199 | RGD:6480464 | CTD | |
| G | SGSM3 | small G protein signaling modulator 3 |
|
multiple interactions | EXP | 22 | 40,766,595 | 40,806,293 | RGD:6480464 | CTD | |
| G | SHANK2 | SH3 and multiple ankyrin repeat domains 2 |
|
decreases expression | EXP | 11 | 70,313,961 | 70,935,808 | RGD:6480464 | CTD | |
| G | SHB | Src homology 2 domain containing adaptor protein B |
|
increases expression | EXP | 9 | 37,915,895 | 38,069,210 | RGD:6480464 | CTD | |
| G | SHFM1 | split hand/foot malformation (ectrodactyly) type 1 |
|
decreases expression | EXP | 7 | 96,318,079 | 96,339,203 | RGD:6480464 | CTD | |
| G | SIAH1 | siah E3 ubiquitin protein ligase 1 |
|
decreases expression | EXP | 16 | 48,394,442 | 48,419,229 | RGD:6480464 | CTD | |
| G | SIGIRR | single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
|
increases expression | EXP | 11 | 405,716 | 417,397 | RGD:6480464 | CTD | |
| G | SIN3B | SIN3 transcription regulator homolog B (yeast) |
|
increases expression | EXP | 19 | 16,940,209 | 16,991,164 | RGD:6480464 | CTD | |
| G | SIPA1L3 | signal-induced proliferation-associated 1 like 3 |
|
increases expression | EXP | 19 | 38,397,868 | 38,699,009 | RGD:6480464 | CTD | |
| G | SIRPA | signal-regulatory protein alpha |
|
increases expression | EXP | 20 | 1,874,813 | 1,920,540 | RGD:6480464 | CTD | |
| G | SIRT1 | sirtuin 1 |
|
decreases expression | EXP | 10 | 69,644,427 | 69,678,147 | RGD:6480464 | CTD | |
| G | SIRT5 | sirtuin 5 |
|
increases expression | EXP | 6 | 13,574,761 | 13,615,390 | RGD:6480464 | CTD | |
| G | SKI | v-ski sarcoma viral oncogene homolog (avian) |
|
increases expression | EXP | 1 | 2,160,134 | 2,241,652 | RGD:6480464 | CTD | |
| G | SLC11A2 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
multiple interactions | EXP | 12 | 51,373,566 | 51,422,058 | RGD:6480464 | CTD | |
| G | SLC12A2 | solute carrier family 12 (sodium/potassium/chloride transporters), member 2 |
|
multiple interactions | EXP | 5 | 127,419,483 | 127,525,380 | RGD:6480464 | CTD | |
| G | SLC13A4 | solute carrier family 13 (sodium/sulfate symporters), member 4 |
|
affects transport | ISO | 7 | 135,365,985 | 135,412,933 | RGD:6480464 | CTD | |
| G | SLC13A4 | solute carrier family 13 (sodium/sulfate symporters), member 4 |
|
multiple interactions | ISO | 7 | 135,365,985 | 135,412,933 | RGD:6480464 | CTD | |
| G | SLC19A1 | solute carrier family 19 (folate transporter), member 1 |
|
decreases expression | EXP | 21 | 46,934,629 | 46,962,385 | RGD:6480464 | CTD | |
| G | SLC19A2 | solute carrier family 19 (thiamine transporter), member 2 |
|
decreases expression | EXP | 1 | 169,433,147 | 169,455,208 | RGD:6480464 | CTD | |
| G | SLC1A1 | solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
decreases expression | EXP | 9 | 4,490,427 | 4,587,469 | RGD:6480464 | CTD | |
| G | SLC22A18 | solute carrier family 22, member 18 |
|
increases expression | EXP | 11 | 2,920,951 | 2,946,476 | RGD:6480464 | CTD | |
| G | SLC25A1 | solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 |
|
increases expression | EXP | 22 | 19,163,088 | 19,166,338 | RGD:6480464 | CTD | |
| G | SLC25A12 | solute carrier family 25 (aspartate/glutamate carrier), member 12 |
|
decreases expression | EXP | 2 | 172,639,915 | 172,750,816 | RGD:6480464 | CTD | |
| G | SLC25A16 | solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16 |
|
multiple interactions | EXP | 10 | 70,242,090 | 70,287,280 | RGD:6480464 | CTD | |
| G | SLC25A16 | solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16 |
|
decreases expression | EXP | 10 | 70,242,090 | 70,287,280 | RGD:6480464 | CTD | |
| G | SLC25A17 | solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kDa), member 17 |
|
decreases expression | EXP | 22 | 41,165,636 | 41,215,392 | RGD:6480464 | CTD | |
| G | SLC25A22 | solute carrier family 25 (mitochondrial carrier: glutamate), member 22 |
|
increases expression | EXP | 11 | 790,475 | 798,269 | RGD:6480464 | CTD | |
| G | SLC25A36 | solute carrier family 25 (pyrimidine nucleotide carrier ), member 36 |
|
decreases expression | EXP | 3 | 140,660,662 | 140,698,785 | RGD:6480464 | CTD | |
| G | SLC25A37 | solute carrier family 25 (mitochondrial iron transporter), member 37 |
|
increases expression | EXP | 8 | 23,386,363 | 23,430,063 | RGD:6480464 | CTD | |
| G | SLC25A6 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 |
|
increases expression | EXP | X Y |
1,505,045 1,455,045 |
1,511,039 1,461,039 |
RGD:6480464 | CTD | |
| G | SLC29A1 | solute carrier family 29 (nucleoside transporters), member 1 |
|
multiple interactions | EXP | 6 | 44,187,242 | 44,201,888 | RGD:6480464 | CTD | |
| G | SLC35D1 | solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 |
|
multiple interactions | EXP | 1 | 67,465,015 | 67,520,080 | RGD:6480464 | CTD | |
| G | SLC35D1 | solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 |
|
decreases expression | EXP | 1 | 67,465,015 | 67,520,080 | RGD:6480464 | CTD | |
| G | SLC39A1 | solute carrier family 39 (zinc transporter), member 1 |
|
multiple interactions | EXP | 1 | 153,931,588 | 153,940,188 | RGD:6480464 | CTD | |
| G | SLC39A7 | solute carrier family 39 (zinc transporter), member 7 |
|
increases expression | EXP | 6 | 33,168,603 | 33,172,214 | RGD:6480464 | CTD | |
| G | SLC3A2 | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
increases expression | EXP | 11 | 62,623,484 | 62,656,355 | RGD:6480464 | CTD | |
| G | SLC44A4 | solute carrier family 44, member 4 |
|
increases expression | EXP | 6 | 31,830,969 | 31,846,823 | RGD:6480464 | CTD | |
| G | SLC4A4 | solute carrier family 4, sodium bicarbonate cotransporter, member 4 |
|
decreases expression | EXP | 4 | 72,053,003 | 72,437,804 | RGD:6480464 | CTD | |
| G | SLC4A7 | solute carrier family 4, sodium bicarbonate cotransporter, member 7 |
|
decreases expression | EXP | 3 | 27,414,212 | 27,525,911 | RGD:6480464 | CTD | |
| G | SLC6A2 | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
|
decreases expression | EXP | 16 | 55,689,542 | 55,740,104 | RGD:6480464 | CTD | |
| G | SLC6A8 | solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
|
increases expression | EXP | X | 152,953,752 | 152,962,048 | RGD:6480464 | CTD | |
| G | SLC7A5 | solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
|
increases expression | EXP | 16 | 87,863,629 | 87,903,100 | RGD:6480464 | CTD | |
| G | SLC7A8 | solute carrier family 7 (amino acid transporter light chain, L system), member 8 |
|
increases expression | EXP | 14 | 23,594,504 | 23,652,869 | RGD:6480464 | CTD | |
| G | SLIT2 | slit homolog 2 (Drosophila) |
|
decreases expression | EXP | 4 | 20,255,235 | 20,620,788 | RGD:6480464 | CTD | |
| G | SMA5 | glucuronidase, beta pseudogene |
|
multiple interactions | EXP | 5 | 69,776,870 | 69,881,549 | RGD:6480464 | CTD | |
| G | SMA5 | glucuronidase, beta pseudogene |
|
decreases expression | EXP | 5 | 69,776,870 | 69,881,549 | RGD:6480464 | CTD | |
| G | SMAD5-AS1 | SMAD5 antisense RNA 1 |
|
increases expression | EXP | 5 | 135,465,202 | 135,470,579 | RGD:6480464 | CTD | |
| G | SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
|
increases expression | EXP | 19 | 11,071,598 | 11,172,958 | RGD:6480464 | CTD | |
| G | SMARCA5 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 |
|
decreases expression | EXP | 4 | 144,434,616 | 144,478,642 | RGD:6480464 | CTD | |
| G | SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
|
decreases expression | EXP | 3 | 47,627,378 | 47,823,405 | RGD:6480464 | CTD | |
| G | SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
|
multiple interactions | EXP | 3 | 47,627,378 | 47,823,405 | RGD:6480464 | CTD | |
| G | SMARCD2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 |
|
multiple interactions | EXP | 17 | 61,909,441 | 61,920,351 | RGD:6480464 | CTD | |
| G | SMARCD2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 |
|
increases expression | EXP | 17 | 61,909,441 | 61,920,351 | RGD:6480464 | CTD | |
| G | SMARCD3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
|
increases expression | EXP | 7 | 150,936,059 | 150,974,231 | RGD:6480464 | CTD | |
| G | SMCHD1 | structural maintenance of chromosomes flexible hinge domain containing 1 |
|
decreases expression | EXP | 18 | 2,655,886 | 2,805,015 | RGD:6480464 | CTD | |
| G | SMG5 | smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans) |
|
multiple interactions | EXP | 1 | 156,219,015 | 156,252,620 | RGD:6480464 | CTD | |
| G | SMG5 | smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans) |
|
increases expression | EXP | 1 | 156,219,015 | 156,252,620 | RGD:6480464 | CTD | |
| G | SMG7 | smg-7 homolog, nonsense mediated mRNA decay factor (C. elegans) |
|
increases expression | EXP | 1 | 183,441,506 | 183,523,328 | RGD:6480464 | CTD | |
| G | SMOX | spermine oxidase |
|
increases expression | EXP | 20 | 4,129,426 | 4,168,394 | RGD:6480464 | CTD | |
| G | SMTN | smoothelin |
|
increases expression | EXP | 22 | 31,477,282 | 31,500,610 | RGD:6480464 | CTD | |
| G | SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 |
|
increases expression | EXP | 7 | 98,625,058 | 98,741,743 | RGD:6480464 | CTD | |
| G | SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 |
|
decreases expression | EXP | 17 | 62,540,735 | 62,658,386 | RGD:6480464 | CTD | |
| G | SNAP25 | synaptosomal-associated protein, 25kDa |
|
multiple interactions | EXP | 20 | 10,199,477 | 10,288,066 | RGD:6480464 | CTD | |
| G | SNAP25 | synaptosomal-associated protein, 25kDa |
|
decreases expression | EXP | 20 | 10,199,477 | 10,288,066 | RGD:6480464 | CTD | |
| G | SNRNP27 | small nuclear ribonucleoprotein 27kDa (U4/U6.U5) |
|
decreases expression | EXP | 2 | 70,121,075 | 70,132,368 | RGD:6480464 | CTD | |
| G | SNRNP35 | small nuclear ribonucleoprotein 35kDa (U11/U12) |
|
increases expression | EXP | 12 | 123,942,651 | 123,950,941 | RGD:6480464 | CTD | |
| G | SNRPB | small nuclear ribonucleoprotein polypeptides B and B1 |
|
increases expression | EXP | 20 | 2,442,281 | 2,451,499 | RGD:6480464 | CTD | |
| G | SNX1 | sorting nexin 1 |
|
increases expression | EXP | 15 | 64,388,083 | 64,436,433 | RGD:6480464 | CTD | |
| G | SNX17 | sorting nexin 17 |
|
increases expression | EXP | 2 | 27,593,363 | 27,600,400 | RGD:6480464 | CTD | |
| G | SOBP | sine oculis binding protein homolog (Drosophila) |
|
decreases expression | EXP | 6 | 107,811,317 | 107,982,513 | RGD:6480464 | CTD | |
| G | SOD1 | superoxide dismutase 1, soluble |
|
decreases expression | ISO | 21 | 33,031,935 | 33,041,244 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
affects response to substance | EXP | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
increases expression | EXP | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
multiple interactions | EXP | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
affects response to substance | EXP | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SON | SON DNA binding protein |
|
multiple interactions | EXP | 21 | 34,915,350 | 34,949,812 | RGD:6480464 | CTD | |
| G | SON | SON DNA binding protein |
|
decreases expression | EXP | 21 | 34,915,350 | 34,949,812 | RGD:6480464 | CTD | |
| G | SORBS3 | sorbin and SH3 domain containing 3 |
|
increases expression | EXP | 8 | 22,409,251 | 22,433,008 | RGD:6480464 | CTD | |
| G | SORD | sorbitol dehydrogenase |
|
increases expression | ISO | 15 | 45,315,302 | 45,367,287 | RGD:6480464 | CTD | |
| G | SOS1 | son of sevenless homolog 1 (Drosophila) |
|
multiple interactions | EXP | 2 | 39,208,690 | 39,347,604 | RGD:6480464 | CTD | |
| G | SOS1 | son of sevenless homolog 1 (Drosophila) |
|
decreases expression | EXP | 2 | 39,208,690 | 39,347,604 | RGD:6480464 | CTD | |
| G | SOX2 | SRY (sex determining region Y)-box 2 |
|
increases expression | EXP | 3 | 181,429,712 | 181,432,224 | RGD:6480464 | CTD | |
| G | SOX4 | SRY (sex determining region Y)-box 4 |
|
multiple interactions | EXP | 6 | 21,593,972 | 21,598,850 | RGD:6480464 | CTD | |
| G | SOX4 | SRY (sex determining region Y)-box 4 |
|
decreases expression | EXP | 6 | 21,593,972 | 21,598,850 | RGD:6480464 | CTD | |
| G | SOX9 | SRY (sex determining region Y)-box 9 |
|
multiple interactions | EXP | 17 | 70,117,161 | 70,122,561 | RGD:6480464 | CTD | |
| G | SOX9 | SRY (sex determining region Y)-box 9 |
|
decreases expression | EXP | 17 | 70,117,161 | 70,122,561 | RGD:6480464 | CTD | |
| G | SP100 | SP100 nuclear antigen |
|
decreases expression | EXP | 2 | 231,280,871 | 231,410,317 | RGD:6480464 | CTD | |
| G | SPCS2 | signal peptidase complex subunit 2 homolog (S. cerevisiae) |
|
multiple interactions | EXP | 11 | 74,660,292 | 74,690,076 | RGD:6480464 | CTD | |
| G | SPCS2 | signal peptidase complex subunit 2 homolog (S. cerevisiae) |
|
decreases expression | EXP | 11 | 74,660,292 | 74,690,076 | RGD:6480464 | CTD | |
| G | SPEN | spen homolog, transcriptional regulator (Drosophila) |
|
multiple interactions | EXP | 1 | 16,174,359 | 16,266,950 | RGD:6480464 | CTD | |
| G | SPEN | spen homolog, transcriptional regulator (Drosophila) |
|
decreases expression | EXP | 1 | 16,174,359 | 16,266,950 | RGD:6480464 | CTD | |
| G | SPG7 | spastic paraplegia 7 (pure and complicated autosomal recessive) |
|
increases expression | EXP | 16 | 89,574,805 | 89,624,174 | RGD:6480464 | CTD | |
| G | SPINT1 | serine peptidase inhibitor, Kunitz type 1 |
|
increases expression | EXP | 15 | 41,136,246 | 41,149,853 | RGD:6480464 | CTD | |
| G | SPP1 | secreted phosphoprotein 1 |
|
decreases expression | ISO | 4 | 88,896,802 | 88,904,563 | RGD:6480464 | CTD | |
| G | SPSB3 | splA/ryanodine receptor domain and SOCS box containing 3 |
|
multiple interactions | EXP | 16 | 1,826,713 | 1,832,581 | RGD:6480464 | CTD | |
| G | SPSB3 | splA/ryanodine receptor domain and SOCS box containing 3 |
|
increases expression | EXP | 16 | 1,826,713 | 1,832,581 | RGD:6480464 | CTD | |
| G | SPTAN1 | spectrin, alpha, non-erythrocytic 1 |
|
multiple interactions | EXP | 9 | 131,314,837 | 131,395,944 | RGD:6480464 | CTD | |
| G | SPTAN1 | spectrin, alpha, non-erythrocytic 1 |
|
increases expression | EXP | 9 | 131,314,837 | 131,395,944 | RGD:6480464 | CTD | |
| G | SREBF1 | sterol regulatory element binding transcription factor 1 |
|
increases expression | ISO | 17 | 17,714,663 | 17,740,325 | RGD:6480464 | CTD | |
| G | SREBF2 | sterol regulatory element binding transcription factor 2 |
|
increases expression | EXP | 22 | 42,229,106 | 42,302,375 | RGD:6480464 | CTD | |
| G | SRPK1 | SRSF protein kinase 1 |
|
multiple interactions | EXP | 6 | 35,800,811 | 35,888,957 | RGD:6480464 | CTD | |
| G | SRPK1 | SRSF protein kinase 1 |
|
decreases expression | EXP | 6 | 35,800,811 | 35,888,957 | RGD:6480464 | CTD | |
| G | SRRM2 | serine/arginine repetitive matrix 2 |
|
multiple interactions | EXP | 16 | 2,802,330 | 2,821,413 | RGD:6480464 | CTD | |
| G | SRSF1 | serine/arginine-rich splicing factor 1 |
|
increases expression | EXP | 17 | 56,078,280 | 56,084,707 | RGD:6480464 | CTD | |
| G | SRSF10 | serine/arginine-rich splicing factor 10 |
|
decreases expression | EXP | 1 | 24,292,935 | 24,306,953 | RGD:6480464 | CTD | |
| G | SRSF11 | serine/arginine-rich splicing factor 11 |
|
decreases expression | EXP | 1 | 70,671,365 | 70,717,703 | RGD:6480464 | CTD | |
| G | SRSF7 | serine/arginine-rich splicing factor 7 |
|
multiple interactions | EXP | 2 | 38,970,741 | 38,978,636 | RGD:6480464 | CTD | |
| G | SRSF7 | serine/arginine-rich splicing factor 7 |
|
decreases expression | EXP | 2 | 38,970,741 | 38,978,636 | RGD:6480464 | CTD | |
| G | SRSF9 | serine/arginine-rich splicing factor 9 |
|
increases expression | EXP | 12 | 120,899,471 | 120,907,558 | RGD:6480464 | CTD | |
| G | SS18L2 | synovial sarcoma translocation gene on chromosome 18-like 2 |
|
decreases expression | EXP | 3 | 42,632,298 | 42,636,490 | RGD:6480464 | CTD | |
| G | SSNA1 | Sjogren syndrome nuclear autoantigen 1 |
|
increases expression | EXP | 9 | 140,083,054 | 140,084,822 | RGD:6480464 | CTD | |
| G | SSRP1 | structure specific recognition protein 1 |
|
increases expression | EXP | 11 | 57,093,459 | 57,103,351 | RGD:6480464 | CTD | |
| G | SSX2IP | synovial sarcoma, X breakpoint 2 interacting protein |
|
decreases expression | EXP | 1 | 85,109,390 | 85,156,240 | RGD:6480464 | CTD | |
| G | ST13 | suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) |
|
multiple interactions | ISO | 22 | 41,220,599 | 41,252,687 | RGD:6480464 | CTD | |
| G | ST14 | suppression of tumorigenicity 14 (colon carcinoma) |
|
increases expression | EXP | 11 | 130,029,682 | 130,080,257 | RGD:6480464 | CTD | |
| G | ST5 | suppression of tumorigenicity 5 |
|
increases expression | EXP | 11 | 8,714,899 | 8,932,498 | RGD:6480464 | CTD | |
| G | STAB1 | stabilin 1 |
|
multiple interactions | EXP | 3 | 52,529,356 | 52,558,511 | RGD:6480464 | CTD | |
| G | STAB1 | stabilin 1 |
|
increases expression | EXP | 3 | 52,529,356 | 52,558,511 | RGD:6480464 | CTD | |
| G | STAG2 | stromal antigen 2 |
|
decreases expression | EXP | X | 123,094,475 | 123,236,506 | RGD:6480464 | CTD | |
| G | STARD5 | StAR-related lipid transfer (START) domain containing 5 |
|
multiple interactions | EXP | 15 | 81,605,007 | 81,616,524 | RGD:6480464 | CTD | |
| G | STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions | EXP | 17 | 40,465,343 | 40,540,513 | RGD:6480464 | CTD | |
| G | STBD1 | starch binding domain 1 |
|
increases expression | EXP | 4 | 77,227,179 | 77,232,283 | RGD:6480464 | CTD | |
| G | STEAP4 | STEAP family member 4 |
|
increases expression | EXP | 7 | 87,905,744 | 87,936,228 | RGD:6480464 | CTD | |
| G | STK11 | serine/threonine kinase 11 |
|
increases expression | EXP | 19 | 1,205,798 | 1,228,434 | RGD:6480464 | CTD | |
| G | STK24 | serine/threonine kinase 24 |
|
increases expression | EXP | 13 | 99,102,455 | 99,229,396 | RGD:6480464 | CTD | |
| G | STK38L | serine/threonine kinase 38 like |
|
decreases expression | EXP | 12 | 27,397,078 | 27,478,892 | RGD:6480464 | CTD | |
| G | STOML2 | stomatin (EPB72)-like 2 |
|
increases expression | EXP | 9 | 35,099,893 | 35,103,154 | RGD:6480464 | CTD | |
| G | STUB1 | STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase |
|
increases expression | EXP | 16 | 730,115 | 732,768 | RGD:6480464 | CTD | |
| G | STYXL1 | serine/threonine/tyrosine interacting-like 1 |
|
increases expression | EXP | 7 | 75,625,655 | 75,677,321 | RGD:6480464 | CTD | |
| G | SULF1 | sulfatase 1 |
|
decreases expression | EXP | 8 | 70,378,859 | 70,573,147 | RGD:6480464 | CTD | |
| G | SUMO2 | small ubiquitin-like modifier 2 |
|
increases expression | EXP | 17 | 73,163,825 | 73,179,098 | RGD:6480464 | CTD | |
| G | SUPT5H | suppressor of Ty 5 homolog (S. cerevisiae) |
|
multiple interactions | EXP | 19 | 39,936,186 | 39,967,310 | RGD:6480464 | CTD | |
| G | SUPT5H | suppressor of Ty 5 homolog (S. cerevisiae) |
|
increases expression | EXP | 19 | 39,936,186 | 39,967,310 | RGD:6480464 | CTD | |
| G | SUPT7L | suppressor of Ty 7 (S. cerevisiae)-like |
|
decreases expression | EXP | 2 | 27,873,679 | 27,886,449 | RGD:6480464 | CTD | |
| G | SUZ12 | SUZ12 polycomb repressive complex 2 subunit |
|
decreases expression | EXP | 17 | 30,264,044 | 30,328,057 | RGD:6480464 | CTD | |
| G | SYNCRIP | synaptotagmin binding, cytoplasmic RNA interacting protein |
|
decreases expression | EXP | 6 | 86,317,502 | 86,353,043 | RGD:6480464 | CTD | |
| G | SYNJ2 | synaptojanin 2 |
|
increases expression | EXP | 6 | 158,402,888 | 158,520,208 | RGD:6480464 | CTD | |
| G | SYNPO | synaptopodin |
|
increases expression | EXP | 5 | 149,980,642 | 150,038,792 | RGD:6480464 | CTD | |
| G | TADA3 | transcriptional adaptor 3 |
|
increases expression | EXP | 3 | 9,821,651 | 9,834,420 | RGD:6480464 | CTD | |
| G | TAF10 | TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa |
|
increases expression | EXP | 11 | 6,632,048 | 6,633,475 | RGD:6480464 | CTD | |
| G | TAF2 | TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa |
|
decreases expression | EXP | 8 | 120,743,014 | 120,845,074 | RGD:6480464 | CTD | |
| G | TAF5L | TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa |
|
decreases expression | EXP | 1 | 229,728,858 | 229,761,794 | RGD:6480464 | CTD | |
| G | TAGLN2 | transgelin 2 |
|
increases expression | EXP | 1 | 159,887,903 | 159,895,284 | RGD:6480464 | CTD | |
| G | TALDO1 | transaldolase 1 |
|
increases expression | EXP | 11 | 747,432 | 765,024 | RGD:6480464 | CTD | |
| G | TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
|
increases expression | EXP | 6 | 32,812,986 | 32,821,748 | RGD:6480464 | CTD | |
| G | TAPBP | TAP binding protein (tapasin) |
|
increases expression | EXP | 6 | 33,267,471 | 33,282,164 | RGD:6480464 | CTD | |
| G | TARBP2 | TAR (HIV-1) RNA binding protein 2 |
|
increases expression | EXP | 12 | 53,894,705 | 53,900,215 | RGD:6480464 | CTD | |
| G | TARBP2 | TAR (HIV-1) RNA binding protein 2 |
|
multiple interactions | EXP | 12 | 53,894,705 | 53,900,215 | RGD:6480464 | CTD | |
| G | TARP | TCR gamma alternate reading frame protein |
|
decreases expression | EXP | 7 | 38,299,244 | 38,313,248 | RGD:6480464 | CTD | |
| G | TAS2R14 | taste receptor, type 2, member 14 |
|
multiple interactions | EXP | 12 | 11,090,853 | 11,091,806 | RGD:6480464 | CTD | |
| G | TAX1BP3 | Tax1 (human T-cell leukemia virus type I) binding protein 3 |
|
increases expression | EXP | 17 | 3,566,187 | 3,571,973 | RGD:6480464 | CTD | |
| G | TBC1D30 | TBC1 domain family, member 30 |
|
decreases expression | EXP | 12 | 65,218,352 | 65,274,802 | RGD:6480464 | CTD | |
| G | TBC1D8B | TBC1 domain family, member 8B (with GRAM domain) |
|
multiple interactions | EXP | X | 106,045,919 | 106,119,380 | RGD:6480464 | CTD | |
| G | TBC1D8B | TBC1 domain family, member 8B (with GRAM domain) |
|
decreases expression | EXP | X | 106,045,919 | 106,119,380 | RGD:6480464 | CTD | |
| G | TBC1D9B | TBC1 domain family, member 9B (with GRAM domain) |
|
multiple interactions | EXP | 5 | 179,289,071 | 179,334,856 | RGD:6480464 | CTD | |
| G | TBC1D9B | TBC1 domain family, member 9B (with GRAM domain) |
|
increases expression | EXP | 5 | 179,289,071 | 179,334,856 | RGD:6480464 | CTD | |
| G | TBL1X | transducin (beta)-like 1X-linked |
|
decreases expression | EXP | X | 9,431,335 | 9,687,780 | RGD:6480464 | CTD | |
| G | TBL3 | transducin (beta)-like 3 |
|
increases expression | EXP | 16 | 2,022,064 | 2,028,751 | RGD:6480464 | CTD | |
| G | TCEA2 | transcription elongation factor A (SII), 2 |
|
multiple interactions | EXP | 20 | 62,688,439 | 62,703,700 | RGD:6480464 | CTD | |
| G | TCEA2 | transcription elongation factor A (SII), 2 |
|
increases expression | EXP | 20 | 62,688,439 | 62,703,700 | RGD:6480464 | CTD | |
| G | TCEB3 | transcription elongation factor B (SIII), polypeptide 3 (110kDa, elongin A) |
|
multiple interactions | EXP | 1 | 24,069,856 | 24,088,549 | RGD:6480464 | CTD | |
| G | TCERG1 | transcription elongation regulator 1 |
|
multiple interactions | EXP | 5 | 145,826,873 | 145,891,069 | RGD:6480464 | CTD | |
| G | TCERG1 | transcription elongation regulator 1 |
|
decreases expression | EXP | 5 | 145,826,873 | 145,891,069 | RGD:6480464 | CTD | |
| G | TCF12 | transcription factor 12 |
|
decreases expression | EXP | 15 | 57,210,833 | 57,580,716 | RGD:6480464 | CTD | |
| G | TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) |
|
multiple interactions | EXP | 10 | 114,710,009 | 114,927,437 | RGD:6480464 | CTD | |
| G | TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) |
|
decreases expression | EXP | 10 | 114,710,009 | 114,927,437 | RGD:6480464 | CTD | |
| G | TCP1 | t-complex 1 |
|
multiple interactions | ISO | 6 | 160,199,530 | 160,210,735 | RGD:6480464 | CTD | |
| G | TCTN1 | tectonic family member 1 |
|
multiple interactions | EXP | 12 | 111,051,832 | 111,086,935 | RGD:6480464 | CTD | |
| G | TCTN1 | tectonic family member 1 |
|
decreases expression | EXP | 12 | 111,051,832 | 111,086,935 | RGD:6480464 | CTD | |
| G | TEAD3 | TEA domain family member 3 |
|
increases expression | EXP | 6 | 35,441,374 | 35,464,861 | RGD:6480464 | CTD | |
| G | TENC1 | tensin like C1 domain containing phosphatase (tensin 2) |
|
increases expression | EXP | 12 | 53,440,810 | 53,458,163 | RGD:6480464 | CTD | |
| G | TEP1 | telomerase-associated protein 1 |
|
increases expression | EXP | 14 | 20,833,826 | 20,881,579 | RGD:6480464 | CTD | |
| G | TERF1 | telomeric repeat binding factor (NIMA-interacting) 1 |
|
decreases expression | EXP | 8 | 73,921,097 | 73,959,987 | RGD:6480464 | CTD | |
| G | TERF1 | telomeric repeat binding factor (NIMA-interacting) 1 |
|
multiple interactions | EXP | 8 | 73,921,097 | 73,959,987 | RGD:6480464 | CTD | |
| G | TERT | telomerase reverse transcriptase |
|
decreases activity | EXP | 5 | 1,253,282 | 1,295,162 | RGD:6480464 | CTD | |
| G | TERT | telomerase reverse transcriptase |
|
decreases expression | EXP | 5 | 1,253,282 | 1,295,162 | RGD:6480464 | CTD | |
| G | TERT | telomerase reverse transcriptase |
|
multiple interactions | ISO | 5 | 1,253,282 | 1,295,162 | RGD:6480464 | CTD | |
| G | TFAM | transcription factor A, mitochondrial |
|
multiple interactions | ISO | 10 | 60,144,903 | 60,158,990 | RGD:6480464 | CTD | |
| G | TFAM | transcription factor A, mitochondrial |
|
increases expression | ISO | 10 | 60,144,903 | 60,158,990 | RGD:6480464 | CTD | |
| G | TFB2M | transcription factor B2, mitochondrial |
|
decreases expression | EXP | 1 | 246,703,863 | 246,729,565 | RGD:6480464 | CTD | |
| G | TFEB | transcription factor EB |
|
increases expression | EXP | 6 | 41,651,716 | 41,703,997 | RGD:6480464 | CTD | |
| G | TGFB1 | transforming growth factor, beta 1 |
|
multiple interactions | ISO | 19 | 41,836,812 | 41,859,831 | RGD:6480464 | CTD | |
| G | TGFB1 | transforming growth factor, beta 1 |
|
increases expression | ISO | 19 | 41,836,812 | 41,859,831 | RGD:6480464 | CTD | |
| G | TGFBR3 | transforming growth factor, beta receptor III |
|
decreases expression | EXP | 1 | 92,145,900 | 92,371,559 | RGD:6480464 | CTD | |
| G | TGOLN2 | trans-golgi network protein 2 |
|
multiple interactions | EXP | 2 | 85,545,141 | 85,555,419 | RGD:6480464 | CTD | |
| G | TH | tyrosine hydroxylase |
|
increases activity | ISO | 11 | 2,185,159 | 2,193,035 | RGD:6480464 | CTD | |
| G | TH | tyrosine hydroxylase |
|
multiple interactions | ISO | 11 | 2,185,159 | 2,193,035 | RGD:6480464 | CTD | |
| G | TH | tyrosine hydroxylase |
|
increases expression | ISO | 11 | 2,185,159 | 2,193,035 | RGD:6480464 | CTD | |
| G | THAP11 | THAP domain containing 11 |
|
increases expression | EXP | 16 | 67,876,213 | 67,878,098 | RGD:6480464 | CTD | |
| G | THAP7 | THAP domain containing 7 |
|
increases expression | EXP | 22 | 21,354,061 | 21,356,404 | RGD:6480464 | CTD | |
| G | THBD | thrombomodulin |
|
multiple interactions | EXP | 20 | 23,026,270 | 23,030,301 | RGD:6480464 | CTD | |
| G | THOC2 | THO complex 2 |
|
decreases expression | EXP | X | 122,734,412 | 122,866,904 | RGD:6480464 | CTD | |
| G | THOC2 | THO complex 2 |
|
multiple interactions | EXP | X | 122,734,412 | 122,866,904 | RGD:6480464 | CTD | |
| G | THRA | thyroid hormone receptor, alpha |
|
multiple interactions | ISO | 17 | 38,218,446 | 38,250,120 | RGD:6480464 | CTD | |
| G | THRB | thyroid hormone receptor, beta |
|
multiple interactions | ISO | 3 | 24,158,644 | 24,536,313 | RGD:6480464 | CTD | |
| G | THSD7A | thrombospondin, type I, domain containing 7A |
|
decreases expression | EXP | 7 | 11,410,062 | 11,871,824 | RGD:6480464 | CTD | |
| G | THUMPD1 | THUMP domain containing 1 |
|
decreases expression | EXP | 16 | 20,744,986 | 20,753,199 | RGD:6480464 | CTD | |
| G | THYN1 | thymocyte nuclear protein 1 |
|
increases expression | EXP | 11 | 134,118,173 | 134,123,260 | RGD:6480464 | CTD | |
| G | TIA1 | TIA1 cytotoxic granule-associated RNA binding protein |
|
multiple interactions | EXP | 2 | 70,436,576 | 70,475,779 | RGD:6480464 | CTD | |
| G | TIA1 | TIA1 cytotoxic granule-associated RNA binding protein |
|
decreases expression | EXP | 2 | 70,436,576 | 70,475,779 | RGD:6480464 | CTD | |
| G | TIAF1 | TGFB1-induced anti-apoptotic factor 1 |
|
multiple interactions | EXP | 17 | 27,400,539 | 27,402,627 | RGD:6480464 | CTD | |
| G | TIAF1 | TGFB1-induced anti-apoptotic factor 1 |
|
increases expression | EXP | 17 | 27,400,539 | 27,402,627 | RGD:6480464 | CTD | |
| G | TIMM8A | translocase of inner mitochondrial membrane 8 homolog A (yeast) |
|
decreases expression | EXP | X | 100,600,644 | 100,603,957 | RGD:6480464 | CTD | |
| G | TIMM8B | translocase of inner mitochondrial membrane 8 homolog B (yeast) |
|
decreases expression | EXP | 11 | 111,955,524 | 111,957,522 | RGD:6480464 | CTD | |
| G | TIMM9 | translocase of inner mitochondrial membrane 9 homolog (yeast) |
|
decreases expression | EXP | 14 | 58,875,370 | 58,894,232 | RGD:6480464 | CTD | |
| G | TIMP1 | TIMP metallopeptidase inhibitor 1 |
|
decreases expression | EXP | X | 47,441,690 | 47,446,190 | RGD:6480464 | CTD | |
| G | TIMP1 | TIMP metallopeptidase inhibitor 1 |
|
increases expression | ISO | X | 47,441,690 | 47,446,190 | RGD:6480464 | CTD | |
| G | TIMP2 | TIMP metallopeptidase inhibitor 2 |
|
decreases expression | EXP | 17 | 76,849,059 | 76,921,472 | RGD:6480464 | CTD | |
| G | TIMP3 | TIMP metallopeptidase inhibitor 3 |
|
increases expression | EXP | 22 | 33,196,802 | 33,259,028 | RGD:6480464 | CTD | |
| G | TIMP3 | TIMP metallopeptidase inhibitor 3 |
|
decreases expression | EXP | 22 | 33,196,802 | 33,259,028 | RGD:6480464 | CTD | |
| G | TIMP4 | TIMP metallopeptidase inhibitor 4 |
|
decreases expression | EXP | 3 | 12,194,568 | 12,200,851 | RGD:6480464 | CTD | |
| G | TJP1 | tight junction protein 1 |
|
multiple interactions | EXP | 15 | 29,992,356 | 30,114,706 | RGD:6480464 | CTD | |
| G | TKT | transketolase |
|
increases expression | EXP | 3 | 53,258,723 | 53,290,130 | RGD:6480464 | CTD | |
| G | TLE2 | transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
|
increases expression | EXP | 19 | 2,997,636 | 3,047,633 | RGD:6480464 | CTD | |
| G | TLN1 | talin 1 |
|
increases expression | EXP | 9 | 35,697,334 | 35,732,392 | RGD:6480464 | CTD | |
| G | TM2D1 | TM2 domain containing 1 |
|
decreases expression | EXP | 1 | 62,146,719 | 62,191,095 | RGD:6480464 | CTD | |
| G | TM9SF1 | transmembrane 9 superfamily member 1 |
|
multiple interactions | EXP | 14 | 24,658,353 | 24,664,882 | RGD:6480464 | CTD | |
| G | TM9SF4 | transmembrane 9 superfamily protein member 4 |
|
increases expression | EXP | 20 | 30,697,309 | 30,755,061 | RGD:6480464 | CTD | |
| G | TMC5 | transmembrane channel-like 5 |
|
multiple interactions | EXP | 16 | 19,422,057 | 19,510,435 | RGD:6480464 | CTD | |
| G | TMEM168 | transmembrane protein 168 |
|
decreases expression | EXP | 7 | 112,405,787 | 112,430,478 | RGD:6480464 | CTD | |
| G | TMEM222 | transmembrane protein 222 |
|
increases expression | EXP | 1 | 27,648,636 | 27,662,891 | RGD:6480464 | CTD | |
| G | TMEM53 | transmembrane protein 53 |
|
increases expression | EXP | 1 | 45,119,501 | 45,140,099 | RGD:6480464 | CTD | |
| G | TMEM63A | transmembrane protein 63A |
|
increases expression | EXP | 1 | 226,033,233 | 226,070,420 | RGD:6480464 | CTD | |
| G | TMF1 | TATA element modulatory factor 1 |
|
decreases expression | EXP | 3 | 69,068,978 | 69,101,484 | RGD:6480464 | CTD | |
| G | TMPRSS2 | transmembrane protease, serine 2 |
|
increases expression | EXP | 21 | 42,836,478 | 42,880,085 | RGD:6480464 | CTD | |
| G | TMPRSS6 | transmembrane protease, serine 6 |
|
increases expression | EXP | 22 | 37,461,479 | 37,499,693 | RGD:6480464 | CTD | |
| G | TMSB15A | thymosin beta 15a |
|
decreases expression | EXP | X | 101,768,610 | 101,771,699 | RGD:6480464 | CTD | |
| G | TMSB15B | thymosin beta 15B |
|
decreases expression | EXP | X | 103,217,200 | 103,220,563 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | EXP | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | EXP | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
increases expression | EXP | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 |
|
increases expression | EXP | 14 | 103,592,664 | 103,603,776 | RGD:6480464 | CTD | |
| G | TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 |
|
increases expression | EXP | 2 | 152,214,106 | 152,236,562 | RGD:6480464 | CTD | |
| G | TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b |
|
increases expression | EXP | 8 | 22,877,646 | 22,926,700 | RGD:6480464 | CTD | |
| G | TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain |
|
increases expression | EXP | 8 | 22,960,327 | 22,974,950 | RGD:6480464 | CTD | |
| G | TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A |
|
increases expression | EXP | 16 | 3,070,313 | 3,072,384 | RGD:6480464 | CTD | |
| G | TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 |
|
decreases expression | EXP | 3 | 172,223,298 | 172,241,297 | RGD:6480464 | CTD | |
| G | TNK1 | tyrosine kinase, non-receptor, 1 |
|
increases expression | EXP | 17 | 7,284,293 | 7,293,093 | RGD:6480464 | CTD | |
| G | TNPO2 | transportin 2 |
|
decreases expression | EXP | 19 | 12,810,008 | 12,834,810 | RGD:6480464 | CTD | |
| G | TOB2 | transducer of ERBB2, 2 |
|
multiple interactions | EXP | 22 | 41,829,492 | 41,843,027 | RGD:6480464 | CTD | |
| G | TOMM7 | translocase of outer mitochondrial membrane 7 homolog (yeast) |
|
decreases expression | EXP | 7 | 22,852,251 | 22,862,421 | RGD:6480464 | CTD | |
| G | TOP1 | topoisomerase (DNA) I |
|
decreases expression | EXP | 20 | 39,657,462 | 39,753,127 | RGD:6480464 | CTD | |
| G | TOP1 | topoisomerase (DNA) I |
|
multiple interactions | EXP | 20 | 39,657,462 | 39,753,127 | RGD:6480464 | CTD | |
| G | TOR3A | torsin family 3, member A |
|
multiple interactions | EXP | 1 | 179,051,112 | 179,065,131 | RGD:6480464 | CTD | |
| G | TOX4 | TOX high mobility group box family member 4 |
|
increases expression | EXP | 14 | 21,945,335 | 21,967,319 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
multiple interactions | EXP | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
multiple interactions | EXP | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
decreases expression | EXP | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
increases expression | EXP | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
multiple interactions | ISO | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TPI1 | triosephosphate isomerase 1 |
|
increases expression | EXP | 12 | 6,976,584 | 6,980,110 | RGD:6480464 | CTD | |
| G | TPM2 | tropomyosin 2 (beta) |
|
increases expression | EXP | 9 | 35,681,990 | 35,690,053 | RGD:6480464 | CTD | |
| G | TPP1 | tripeptidyl peptidase I |
|
multiple interactions | EXP | 11 | 6,633,997 | 6,640,692 | RGD:6480464 | CTD | |
| G | TPP1 | tripeptidyl peptidase I |
|
increases expression | EXP | 11 | 6,633,997 | 6,640,692 | RGD:6480464 | CTD | |
| G | TPR | translocated promoter region, nuclear basket protein |
|
multiple interactions | EXP | 1 | 186,280,784 | 186,344,457 | RGD:6480464 | CTD | |
| G | TPR | translocated promoter region, nuclear basket protein |
|
decreases expression | EXP | 1 | 186,280,784 | 186,344,457 | RGD:6480464 | CTD | |
| G | TRA2A | transformer 2 alpha homolog (Drosophila) |
|
decreases expression | EXP | 7 | 23,544,399 | 23,571,656 | RGD:6480464 | CTD | |
| G | TRA2A | transformer 2 alpha homolog (Drosophila) |
|
increases expression | EXP | 7 | 23,544,399 | 23,571,656 | RGD:6480464 | CTD | |
| G | TRAF4 | TNF receptor-associated factor 4 |
|
multiple interactions | EXP | 17 | 27,071,023 | 27,077,976 | RGD:6480464 | CTD | |
| G | TRAF4 | TNF receptor-associated factor 4 |
|
increases expression | EXP | 17 | 27,071,023 | 27,077,976 | RGD:6480464 | CTD | |
| G | TRAFD1 | TRAF-type zinc finger domain containing 1 |
|
increases expression | EXP | 12 | 112,563,349 | 112,591,408 | RGD:6480464 | CTD | |
| G | TRAPPC2P1 | trafficking protein particle complex 2 pseudogene 1 |
|
decreases expression | EXP | 19 | 57,874,879 | 57,876,721 | RGD:6480464 | CTD | |
| G | TRAPPC8 | trafficking protein particle complex 8 |
|
decreases expression | EXP | 18 | 29,409,136 | 29,523,091 | RGD:6480464 | CTD | |
| G | TREX1 | three prime repair exonuclease 1 |
|
increases expression | EXP | 3 | 48,506,919 | 48,509,044 | RGD:6480464 | CTD | |
| G | TRIB2 | tribbles homolog 2 (Drosophila) |
|
increases expression | EXP | 2 | 12,856,998 | 12,882,860 | RGD:6480464 | CTD | |
| G | TRIM24 | tripartite motif containing 24 |
|
multiple interactions | EXP | 7 | 138,145,079 | 138,270,333 | RGD:6480464 | CTD | |
| G | TRIM24 | tripartite motif containing 24 |
|
decreases expression | EXP | 7 | 138,145,079 | 138,270,333 | RGD:6480464 | CTD | |
| G | TRIM27 | tripartite motif containing 27 |
|
decreases expression | EXP | 6 | 28,870,779 | 28,891,768 | RGD:6480464 | CTD | |
| G | TRIM28 | tripartite motif containing 28 |
|
increases expression | EXP | 19 | 59,055,836 | 59,062,082 | RGD:6480464 | CTD | |
| G | TRIM29 | tripartite motif containing 29 |
|
multiple interactions | EXP | 11 | 119,981,994 | 120,008,863 | RGD:6480464 | CTD | |
| G | TRIM29 | tripartite motif containing 29 |
|
increases expression | EXP | 11 | 119,981,994 | 120,008,863 | RGD:6480464 | CTD | |
| G | TRIM36 | tripartite motif containing 36 |
|
decreases expression | EXP | 5 | 114,460,459 | 114,516,243 | RGD:6480464 | CTD | |
| G | TRIM38 | tripartite motif containing 38 |
|
decreases expression | EXP | 6 | 25,962,917 | 25,987,557 | RGD:6480464 | CTD | |
| G | TRIM52 | tripartite motif containing 52 |
|
decreases expression | EXP | 5 | 180,683,373 | 180,688,119 | RGD:6480464 | CTD | |
| G | TRIP6 | thyroid hormone receptor interactor 6 |
|
multiple interactions | EXP | 7 | 100,464,950 | 100,471,076 | RGD:6480464 | CTD | |
| G | TRIP6 | thyroid hormone receptor interactor 6 |
|
increases expression | EXP | 7 | 100,464,950 | 100,471,076 | RGD:6480464 | CTD | |
| G | TRIT1 | tRNA isopentenyltransferase 1 |
|
decreases expression | EXP | 1 | 40,306,703 | 40,349,177 | RGD:6480464 | CTD | |
| G | TRMT11 | tRNA methyltransferase 11 homolog (S. cerevisiae) |
|
decreases expression | EXP | 6 | 126,307,576 | 126,360,422 | RGD:6480464 | CTD | |
| G | TRMT61B | tRNA methyltransferase 61 homolog B (S. cerevisiae) |
|
decreases expression | EXP | 2 | 29,072,687 | 29,093,175 | RGD:6480464 | CTD | |
| G | TRNAU1 | transfer RNA selenocysteine 1 (anticodon UCA) |
|
affects abundance | ISO | MT | 45,981,860 | 45,981,945 | RGD:6480464 | CTD | |
| G | TRO | trophinin |
|
increases expression | EXP | X | 54,946,996 | 54,957,864 | RGD:6480464 | CTD | |
| G | TROVE2 | TROVE domain family, member 2 |
|
decreases expression | EXP | 1 | 193,028,552 | 193,060,907 | RGD:6480464 | CTD | |
| G | TRPC4 | transient receptor potential cation channel, subfamily C, member 4 |
|
decreases expression | EXP | 13 | 38,210,773 | 38,443,939 | RGD:6480464 | CTD | |
| G | TRRAP | transformation/transcription domain-associated protein |
|
increases expression | EXP | 7 | 98,476,113 | 98,610,866 | RGD:6480464 | CTD | |
| G | TSC2 | tuberous sclerosis 2 |
|
multiple interactions | EXP | 16 | 2,097,990 | 2,138,713 | RGD:6480464 | CTD | |
| G | TSC2 | tuberous sclerosis 2 |
|
increases expression | EXP | 16 | 2,097,990 | 2,138,713 | RGD:6480464 | CTD | |
| G | TSPAN14 | tetraspanin 14 |
|
multiple interactions | EXP | 10 | 82,214,038 | 82,282,391 | RGD:6480464 | CTD | |
| G | TSPAN14 | tetraspanin 14 |
|
increases expression | EXP | 10 | 82,214,038 | 82,282,391 | RGD:6480464 | CTD | |
| G | TSSC4 | tumor suppressing subtransferable candidate 4 |
|
increases expression | EXP | 11 | 2,423,523 | 2,425,106 | RGD:6480464 | CTD | |
| G | TSTA3 | tissue specific transplantation antigen P35B |
|
increases expression | EXP | 8 | 144,694,788 | 144,699,732 | RGD:6480464 | CTD | |
| G | TTC17 | tetratricopeptide repeat domain 17 |
|
decreases expression | EXP | 11 | 43,380,435 | 43,516,483 | RGD:6480464 | CTD | |
| G | TTC3 | tetratricopeptide repeat domain 3 |
|
multiple interactions | EXP | 21 | 38,445,571 | 38,575,408 | RGD:6480464 | CTD | |
| G | TTC3 | tetratricopeptide repeat domain 3 |
|
decreases expression | EXP | 21 | 38,445,571 | 38,575,408 | RGD:6480464 | CTD | |
| G | TTC31 | tetratricopeptide repeat domain 31 |
|
decreases expression | EXP | 2 | 74,710,200 | 74,721,691 | RGD:6480464 | CTD | |
| G | TTC31 | tetratricopeptide repeat domain 31 |
|
multiple interactions | EXP | 2 | 74,710,200 | 74,721,691 | RGD:6480464 | CTD | |
| G | TTC37 | tetratricopeptide repeat domain 37 |
|
decreases expression | EXP | 5 | 94,799,599 | 94,890,709 | RGD:6480464 | CTD | |
| G | TUBA1B | tubulin, alpha 1b |
|
increases expression | EXP | 12 | 49,521,565 | 49,525,304 | RGD:6480464 | CTD | |
| G | TUBB | tubulin, beta class I |
|
increases expression | EXP | 6 | 30,688,157 | 30,693,199 | RGD:6480464 | CTD | |
| G | TUBB3 | tubulin, beta 3 class III |
|
increases expression | EXP | 16 | 89,988,417 | 90,002,505 | RGD:6480464 | CTD | |
| G | TUBB3 | tubulin, beta 3 class III |
|
multiple interactions | EXP | 16 | 89,988,417 | 90,002,505 | RGD:6480464 | CTD | |
| G | TUG1 | taurine upregulated 1 (non-protein coding) |
|
decreases expression | EXP | 22 | 31,365,634 | 31,375,381 | RGD:6480464 | CTD | |
| G | TULP3 | tubby like protein 3 |
|
multiple interactions | EXP | 12 | 3,000,033 | 3,050,306 | RGD:6480464 | CTD | |
| G | TULP3 | tubby like protein 3 |
|
decreases expression | EXP | 12 | 3,000,033 | 3,050,306 | RGD:6480464 | CTD | |
| G | TXLNG2P | taxilin gamma 2, pseudogene |
|
multiple interactions | EXP | Y | 21,729,244 | 21,769,056 | RGD:6480464 | CTD | |
| G | TXLNG2P | taxilin gamma 2, pseudogene |
|
decreases expression | EXP | Y | 21,729,244 | 21,769,056 | RGD:6480464 | CTD | |
| G | TXN | thioredoxin |
|
increases expression | ISO | 9 | 113,006,092 | 113,018,920 | RGD:6480464 | CTD | |
| G | TXN | thioredoxin |
|
affects expression | ISO | 9 | 113,006,092 | 113,018,920 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
multiple interactions | EXP | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
multiple interactions | EXP | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
increases activity | EXP | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
affects activity | ISO | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
multiple interactions | EXP | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
decreases expression | ISO | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
increases expression | EXP | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
increases expression | ISO | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
increases activity | ISO | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
affects activity | ISO | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
decreases expression | ISO | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
increases expression | ISO | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD2 | thioredoxin reductase 2 |
|
increases activity | EXP | 22 | 19,863,040 | 19,929,359 | RGD:6480464 | CTD | |
| G | TXNRD2 | thioredoxin reductase 2 |
|
increases expression | ISO | 22 | 19,863,040 | 19,929,359 | RGD:6480464 | CTD | |
| G | TXNRD2 | thioredoxin reductase 2 |
|
decreases expression | ISO | 22 | 19,863,040 | 19,929,359 | RGD:6480464 | CTD | |
| G | TYMP | thymidine phosphorylase |
|
increases expression | EXP | 22 | 50,964,181 | 50,968,514 | RGD:6480464 | CTD | |
| G | U2AF1 | U2 small nuclear RNA auxiliary factor 1 |
|
increases expression | EXP | 21 | 44,513,066 | 44,527,688 | RGD:6480464 | CTD | |
| G | UBA1 | ubiquitin-like modifier activating enzyme 1 |
|
multiple interactions | EXP | X | 47,050,199 | 47,074,527 | RGD:6480464 | CTD | |
| G | UBA1 | ubiquitin-like modifier activating enzyme 1 |
|
increases expression | EXP | X | 47,050,199 | 47,074,527 | RGD:6480464 | CTD | |
| G | UBA52 | ubiquitin A-52 residue ribosomal protein fusion product 1 |
|
decreases expression | EXP | 19 | 18,682,614 | 18,688,270 | RGD:6480464 | CTD | |
| G | UBA7 | ubiquitin-like modifier activating enzyme 7 |
|
increases expression | EXP | 3 | 49,842,638 | 49,851,391 | RGD:6480464 | CTD | |
| G | UBAP2 | ubiquitin associated protein 2 |
|
decreases expression | EXP | 9 | 33,921,691 | 34,048,947 | RGD:6480464 | CTD | |
| G | UBAP2L | ubiquitin associated protein 2-like |
|
increases expression | EXP | 1 | 154,192,655 | 154,243,329 | RGD:6480464 | CTD | |
| G | UBE2L3 | ubiquitin-conjugating enzyme E2L 3 |
|
increases expression | EXP | 22 | 21,903,736 | 21,978,323 | RGD:6480464 | CTD | |
| G | UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 |
|
multiple interactions | EXP | 20 | 48,697,661 | 48,732,496 | RGD:6480464 | CTD | |
| G | UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 |
|
decreases expression | EXP | 20 | 48,697,661 | 48,732,496 | RGD:6480464 | CTD | |
| G | UBE2Z | ubiquitin-conjugating enzyme E2Z |
|
multiple interactions | EXP | 17 | 46,985,731 | 47,006,422 | RGD:6480464 | CTD | |
| G | UBE2Z | ubiquitin-conjugating enzyme E2Z |
|
increases expression | EXP | 17 | 46,985,731 | 47,006,422 | RGD:6480464 | CTD | |
| G | UBE4B | ubiquitination factor E4B |
|
increases expression | EXP | 1 | 10,093,041 | 10,241,297 | RGD:6480464 | CTD | |
| G | UBL3 | ubiquitin-like 3 |
|
decreases expression | EXP | 13 | 30,338,545 | 30,424,820 | RGD:6480464 | CTD | |
| G | UBN1 | ubinuclein 1 |
|
multiple interactions | EXP | 16 | 4,897,912 | 4,932,363 | RGD:6480464 | CTD | |
| G | UBN1 | ubinuclein 1 |
|
decreases expression | EXP | 16 | 4,897,912 | 4,932,363 | RGD:6480464 | CTD | |
| G | UBN1 | ubinuclein 1 |
|
increases expression | EXP | 16 | 4,897,912 | 4,932,363 | RGD:6480464 | CTD | |
| G | UBXN1 | UBX domain protein 1 |
|
increases expression | EXP | 11 | 62,443,972 | 62,446,527 | RGD:6480464 | CTD | |
| G | UBXN6 | UBX domain protein 6 |
|
increases expression | EXP | 19 | 4,445,003 | 4,457,791 | RGD:6480464 | CTD | |
| G | UFD1L | ubiquitin fusion degradation 1 like (yeast) |
|
increases expression | EXP | 22 | 19,437,464 | 19,466,738 | RGD:6480464 | CTD | |
| G | UGCG | UDP-glucose ceramide glucosyltransferase |
|
multiple interactions | EXP | 9 | 114,659,206 | 114,695,439 | RGD:6480464 | CTD | |
| G | UGCG | UDP-glucose ceramide glucosyltransferase |
|
decreases expression | EXP | 9 | 114,659,206 | 114,695,439 | RGD:6480464 | CTD | |
| G | UGT1A7 | UDP glucuronosyltransferase 1 family, polypeptide A7 |
|
increases expression | ISO | 2 | 234,590,584 | 234,681,945 | RGD:6480464 | CTD | |
| G | UGT2B28 | UDP glucuronosyltransferase 2 family, polypeptide B28 |
|
increases expression | ISO | 4 | 70,146,217 | 70,160,768 | RGD:6480464 | CTD | |
| G | UGT2B4 | UDP glucuronosyltransferase 2 family, polypeptide B4 |
|
increases expression | ISO | 4 | 70,345,883 | 70,361,626 | RGD:6480464 | CTD | |
| G | UHRF1BP1L | UHRF1 binding protein 1-like |
|
multiple interactions | EXP | 12 | 100,430,863 | 100,536,642 | RGD:6480464 | CTD | |
| G | UHRF1BP1L | UHRF1 binding protein 1-like |
|
decreases expression | EXP | 12 | 100,430,863 | 100,536,642 | RGD:6480464 | CTD | |
| G | UNC5B | unc-5 homolog B (C. elegans) |
|
increases expression | EXP | 10 | 72,972,292 | 73,062,635 | RGD:6480464 | CTD | |
| G | UPF3A | UPF3 regulator of nonsense transcripts homolog A (yeast) |
|
multiple interactions | EXP | 13 | 115,047,059 | 115,071,292 | RGD:6480464 | CTD | |
| G | UPF3A | UPF3 regulator of nonsense transcripts homolog A (yeast) |
|
decreases expression | EXP | 13 | 115,047,059 | 115,071,292 | RGD:6480464 | CTD | |
| G | UPF3B | UPF3 regulator of nonsense transcripts homolog B (yeast) |
|
decreases expression | EXP | X | 118,967,989 | 118,986,991 | RGD:6480464 | CTD | |
| G | UQCR10 | ubiquinol-cytochrome c reductase, complex III subunit X |
|
decreases expression | EXP | 22 | 30,163,358 | 30,166,402 | RGD:6480464 | CTD | |
| G | UQCRB | ubiquinol-cytochrome c reductase binding protein |
|
decreases expression | EXP | 8 | 97,238,904 | 97,247,862 | RGD:6480464 | CTD | |
| G | UQCRC1 | ubiquinol-cytochrome c reductase core protein I |
|
increases expression | EXP | 3 | 48,636,432 | 48,647,098 | RGD:6480464 | CTD | |
| G | UQCRH | ubiquinol-cytochrome c reductase hinge protein |
|
decreases expression | EXP | 1 | 46,769,380 | 46,782,448 | RGD:6480464 | CTD | |
| G | UQCRQ | ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa |
|
decreases expression | EXP | 5 | 132,202,319 | 132,204,536 | RGD:6480464 | CTD | |
| G | USF2 | upstream transcription factor 2, c-fos interacting |
|
multiple interactions | EXP | 19 | 35,759,896 | 35,770,718 | RGD:6480464 | CTD | |
| G | USF2 | upstream transcription factor 2, c-fos interacting |
|
increases expression | EXP | 19 | 35,759,896 | 35,770,718 | RGD:6480464 | CTD | |
| G | USP3 | ubiquitin specific peptidase 3 |
|
decreases expression | EXP | 15 | 63,796,710 | 63,886,839 | RGD:6480464 | CTD | |
| G | USP33 | ubiquitin specific peptidase 33 |
|
multiple interactions | EXP | 1 | 78,161,672 | 78,225,564 | RGD:6480464 | CTD | |
| G | USP33 | ubiquitin specific peptidase 33 |
|
decreases expression | EXP | 1 | 78,161,672 | 78,225,564 | RGD:6480464 | CTD | |
| G | USP4 | ubiquitin specific peptidase 4 (proto-oncogene) |
|
decreases expression | EXP | 3 | 49,314,577 | 49,377,536 | RGD:6480464 | CTD | |
| G | USP47 | ubiquitin specific peptidase 47 |
|
decreases expression | EXP | 11 | 11,862,970 | 11,980,872 | RGD:6480464 | CTD | |
| G | USP47 | ubiquitin specific peptidase 47 |
|
multiple interactions | EXP | 11 | 11,862,970 | 11,980,872 | RGD:6480464 | CTD | |
| G | USP9X | ubiquitin specific peptidase 9, X-linked |
|
decreases expression | EXP | X | 40,944,888 | 41,095,832 | RGD:6480464 | CTD | |
| G | USP9Y | ubiquitin specific peptidase 9, Y-linked |
|
increases expression | EXP | Y | 14,813,160 | 14,972,768 | RGD:6480464 | CTD | |
| G | USPL1 | ubiquitin specific peptidase like 1 |
|
decreases expression | EXP | 13 | 31,191,830 | 31,233,686 | RGD:6480464 | CTD | |
| G | UTP11L | UTP11-like, U3 small nucleolar ribonucleoprotein, (yeast) |
|
decreases expression | EXP | 1 | 38,478,384 | 38,490,497 | RGD:6480464 | CTD | |
| G | VAMP8 | vesicle-associated membrane protein 8 |
|
increases expression | EXP | 2 | 85,804,614 | 85,809,156 | RGD:6480464 | CTD | |
| G | VARS2 | valyl-tRNA synthetase 2, mitochondrial |
|
increases expression | EXP | 6 | 30,881,982 | 30,894,236 | RGD:6480464 | CTD | |
| G | VAT1 | vesicle amine transport protein 1 homolog (T. californica) |
|
increases expression | EXP | 17 | 41,166,622 | 41,174,459 | RGD:6480464 | CTD | |
| G | VGF | VGF nerve growth factor inducible |
|
multiple interactions | EXP | 7 | 100,805,790 | 100,808,852 | RGD:6480464 | CTD | |
| G | VILL | villin-like |
|
increases expression | EXP | 3 | 38,035,078 | 38,048,676 | RGD:6480464 | CTD | |
| G | VIM | vimentin |
|
increases expression | EXP | 10 | 17,270,258 | 17,279,592 | RGD:6480464 | CTD | |
| G | VIM | vimentin |
|
multiple interactions | ISO | 10 | 17,270,258 | 17,279,592 | RGD:6480464 | CTD | |
| G | VIM | vimentin |
|
increases expression | ISO | 10 | 17,270,258 | 17,279,592 | RGD:6480464 | CTD | |
| G | VIPR1 | vasoactive intestinal peptide receptor 1 |
|
increases expression | EXP | 3 | 42,530,791 | 42,579,065 | RGD:6480464 | CTD | |
| G | VKORC1 | vitamin K epoxide reductase complex, subunit 1 |
|
multiple interactions | EXP | 16 | 31,102,175 | 31,106,276 | RGD:6480464 | CTD | |
| G | VKORC1 | vitamin K epoxide reductase complex, subunit 1 |
|
increases expression | EXP | 16 | 31,102,175 | 31,106,276 | RGD:6480464 | CTD | |
| G | VPS28 | vacuolar protein sorting 28 homolog (S. cerevisiae) |
|
increases expression | EXP | 8 | 145,649,000 | 145,653,927 | RGD:6480464 | CTD | |
| G | VPS39 | vacuolar protein sorting 39 homolog (S. cerevisiae) |
|
multiple interactions | EXP | 15 | 42,450,899 | 42,500,502 | RGD:6480464 | CTD | |
| G | VPS39 | vacuolar protein sorting 39 homolog (S. cerevisiae) |
|
increases expression | EXP | 15 | 42,450,899 | 42,500,502 | RGD:6480464 | CTD | |
| G | VPS4A | vacuolar protein sorting 4 homolog A (S. cerevisiae) |
|
increases expression | EXP | 16 | 69,345,287 | 69,358,946 | RGD:6480464 | CTD | |
| G | VRK3 | vaccinia related kinase 3 |
|
increases expression | EXP | 19 | 50,479,724 | 50,528,805 | RGD:6480464 | CTD | |
| G | WASF2 | WAS protein family, member 2 |
|
increases expression | EXP | 1 | 27,730,734 | 27,816,678 | RGD:6480464 | CTD | |
| G | WASF2 | WAS protein family, member 2 |
|
multiple interactions | EXP | 1 | 27,730,734 | 27,816,678 | RGD:6480464 | CTD | |
| G | WBP2 | WW domain binding protein 2 |
|
increases expression | EXP | 17 | 73,841,780 | 73,851,501 | RGD:6480464 | CTD | |
| G | WDR1 | WD repeat domain 1 |
|
increases expression | EXP | 4 | 10,075,963 | 10,118,573 | RGD:6480464 | CTD | |
| G | WDR19 | WD repeat domain 19 |
|
decreases expression | EXP | 4 | 39,184,024 | 39,287,430 | RGD:6480464 | CTD | |
| G | WDR19 | WD repeat domain 19 |
|
multiple interactions | EXP | 4 | 39,184,024 | 39,287,430 | RGD:6480464 | CTD | |
| G | WDR45 | WD repeat domain 45 |
|
increases expression | EXP | X | 48,932,092 | 48,958,059 | RGD:6480464 | CTD | |
| G | WDR5B | WD repeat domain 5B |
|
decreases expression | EXP | 3 | 122,130,700 | 122,134,882 | RGD:6480464 | CTD | |
| G | WDR6 | WD repeat domain 6 |
|
increases expression | EXP | 3 | 49,044,637 | 49,053,386 | RGD:6480464 | CTD | |
| G | WFDC2 | WAP four-disulfide core domain 2 |
|
increases expression | EXP | 20 | 44,098,394 | 44,110,172 | RGD:6480464 | CTD | |
| G | WNT5B | wingless-type MMTV integration site family, member 5B |
|
increases expression | EXP | 12 | 1,726,222 | 1,756,378 | RGD:6480464 | CTD | |
| G | WRAP53 | WD repeat containing, antisense to TP53 |
|
multiple interactions | EXP | 17 | 7,589,389 | 7,606,820 | RGD:6480464 | CTD | |
| G | WRAP53 | WD repeat containing, antisense to TP53 |
|
increases expression | EXP | 17 | 7,589,389 | 7,606,820 | RGD:6480464 | CTD | |
| G | WSB1 | WD repeat and SOCS box containing 1 |
|
decreases expression | EXP | 17 | 25,621,106 | 25,640,645 | RGD:6480464 | CTD | |
| G | WWP1 | WW domain containing E3 ubiquitin protein ligase 1 |
|
decreases expression | EXP | 8 | 87,354,994 | 87,480,181 | RGD:6480464 | CTD | |
| G | XPO6 | exportin 6 |
|
decreases expression | EXP | 16 | 28,109,297 | 28,223,239 | RGD:6480464 | CTD | |
| G | XPO6 | exportin 6 |
|
multiple interactions | EXP | 16 | 28,109,297 | 28,223,239 | RGD:6480464 | CTD | |
| G | YIPF3 | Yip1 domain family, member 3 |
|
increases expression | EXP | 6 | 43,479,565 | 43,484,728 | RGD:6480464 | CTD | |
| G | YLPM1 | YLP motif containing 1 |
|
decreases expression | EXP | 14 | 75,230,069 | 75,304,013 | RGD:6480464 | CTD | |
| G | YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide |
|
decreases expression | EXP | 17 | 1,247,834 | 1,303,556 | RGD:6480464 | CTD | |
| G | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
|
multiple interactions | EXP | 8 | 101,930,804 | 101,965,623 | RGD:6480464 | CTD | |
| G | ZBTB11 | zinc finger and BTB domain containing 11 |
|
decreases expression | EXP | 3 | 101,368,283 | 101,395,988 | RGD:6480464 | CTD | |
| G | ZBTB44 | zinc finger and BTB domain containing 44 |
|
decreases expression | EXP | 11 | 130,096,572 | 130,184,607 | RGD:6480464 | CTD | |
| G | ZC2HC1A | zinc finger, C2HC-type containing 1A |
|
decreases expression | EXP | 8 | 79,578,282 | 79,632,000 | RGD:6480464 | CTD | |
| G | ZC3H15 | zinc finger CCCH-type containing 15 |
|
decreases expression | EXP | 2 | 187,350,885 | 187,374,088 | RGD:6480464 | CTD | |
| G | ZC3H15 | zinc finger CCCH-type containing 15 |
|
multiple interactions | EXP | 2 | 187,350,885 | 187,374,088 | RGD:6480464 | CTD | |
| G | ZC3HAV1 | zinc finger CCCH-type, antiviral 1 |
|
decreases expression | EXP | 7 | 138,728,266 | 138,794,465 | RGD:6480464 | CTD | |
| G | ZCCHC2 | zinc finger, CCHC domain containing 2 |
|
multiple interactions | EXP | 18 | 60,190,658 | 60,245,818 | RGD:6480464 | CTD | |
| G | ZCCHC2 | zinc finger, CCHC domain containing 2 |
|
decreases expression | EXP | 18 | 60,190,658 | 60,245,818 | RGD:6480464 | CTD | |
| G | ZCCHC24 | zinc finger, CCHC domain containing 24 |
|
decreases expression | EXP | 10 | 81,142,081 | 81,205,383 | RGD:6480464 | CTD | |
| G | ZCCHC6 | zinc finger, CCHC domain containing 6 |
|
decreases expression | EXP | 9 | 88,902,648 | 88,969,402 | RGD:6480464 | CTD | |
| G | ZCCHC8 | zinc finger, CCHC domain containing 8 |
|
decreases expression | EXP | 12 | 122,956,146 | 122,985,543 | RGD:6480464 | CTD | |
| G | ZCWPW1 | zinc finger, CW type with PWWP domain 1 |
|
increases expression | EXP | 7 | 99,998,495 | 100,026,431 | RGD:6480464 | CTD | |
| G | ZCWPW1 | zinc finger, CW type with PWWP domain 1 |
|
multiple interactions | EXP | 7 | 99,998,495 | 100,026,431 | RGD:6480464 | CTD | |
| G | ZEB1 | zinc finger E-box binding homeobox 1 |
|
decreases expression | EXP | 10 | 31,608,101 | 31,818,742 | RGD:6480464 | CTD | |
| G | ZER1 | zyg-11 related, cell cycle regulator |
|
increases expression | EXP | 9 | 131,492,065 | 131,534,198 | RGD:6480464 | CTD | |
| G | ZFP42 | ZFP42 zinc finger protein |
|
increases expression | EXP | 4 | 188,916,925 | 188,926,199 | RGD:6480464 | CTD | |
| G | ZFP42 | ZFP42 zinc finger protein |
|
multiple interactions | EXP | 4 | 188,916,925 | 188,926,199 | RGD:6480464 | CTD | |
| G | ZKSCAN1 | zinc finger with KRAB and SCAN domains 1 |
|
decreases expression | EXP | 7 | 99,613,219 | 99,635,403 | RGD:6480464 | CTD | |
| G | ZMYM2 | zinc finger, MYM-type 2 |
|
decreases expression | EXP | 13 | 20,532,810 | 20,665,968 | RGD:6480464 | CTD | |
| G | ZMYM4 | zinc finger, MYM-type 4 |
|
decreases expression | EXP | 1 | 35,734,568 | 35,887,545 | RGD:6480464 | CTD | |
| G | ZNF12 | zinc finger protein 12 |
|
decreases expression | EXP | 7 | 6,728,064 | 6,746,566 | RGD:6480464 | CTD | |
| G | ZNF12 | zinc finger protein 12 |
|
multiple interactions | EXP | 7 | 6,728,064 | 6,746,566 | RGD:6480464 | CTD | |
| G | ZNF131 | zinc finger protein 131 |
|
decreases expression | EXP | 5 | 43,121,642 | 43,175,836 | RGD:6480464 | CTD | |
| G | ZNF148 | zinc finger protein 148 |
|
decreases expression | EXP | 3 | 124,944,513 | 125,094,198 | RGD:6480464 | CTD | |
| G | ZNF180 | zinc finger protein 180 |
|
decreases expression | EXP | 19 | 44,979,856 | 45,004,574 | RGD:6480464 | CTD | |
| G | ZNF195 | zinc finger protein 195 |
|
multiple interactions | EXP | 11 | 3,379,157 | 3,400,452 | RGD:6480464 | CTD | |
| G | ZNF195 | zinc finger protein 195 |
|
decreases expression | EXP | 11 | 3,379,157 | 3,400,452 | RGD:6480464 | CTD | |
| G | ZNF211 | zinc finger protein 211 |
|
decreases expression | EXP | 19 | 58,144,535 | 58,154,147 | RGD:6480464 | CTD | |
| G | ZNF212 | zinc finger protein 212 |
|
multiple interactions | EXP | 7 | 148,936,742 | 148,952,700 | RGD:6480464 | CTD | |
| G | ZNF212 | zinc finger protein 212 |
|
increases expression | EXP | 7 | 148,936,742 | 148,952,700 | RGD:6480464 | CTD | |
| G | ZNF219 | zinc finger protein 219 |
|
increases expression | EXP | 14 | 21,558,205 | 21,572,863 | RGD:6480464 | CTD | |
| G | ZNF219 | zinc finger protein 219 |
|
multiple interactions | EXP | 14 | 21,558,205 | 21,572,863 | RGD:6480464 | CTD | |
| G | ZNF26 | zinc finger protein 26 |
|
multiple interactions | EXP | 12 | 133,562,934 | 133,589,154 | RGD:6480464 | CTD | |
| G | ZNF26 | zinc finger protein 26 |
|
decreases expression | EXP | 12 | 133,562,934 | 133,589,154 | RGD:6480464 | CTD | |
| G | ZNF264 | zinc finger protein 264 |
|
decreases expression | EXP | 19 | 57,702,868 | 57,734,214 | RGD:6480464 | CTD | |
| G | ZNF274 | zinc finger protein 274 |
|
multiple interactions | EXP | 19 | 58,694,396 | 58,724,927 | RGD:6480464 | CTD | |
| G | ZNF274 | zinc finger protein 274 |
|
decreases expression | EXP | 19 | 58,694,396 | 58,724,927 | RGD:6480464 | CTD | |
| G | ZNF324 | zinc finger protein 324 |
|
multiple interactions | EXP | 19 | 58,978,412 | 58,984,945 | RGD:6480464 | CTD | |
| G | ZNF324 | zinc finger protein 324 |
|
increases expression | EXP | 19 | 58,978,412 | 58,984,945 | RGD:6480464 | CTD | |
| G | ZNF337 | zinc finger protein 337 |
|
decreases expression | EXP | 20 | 25,654,851 | 25,677,469 | RGD:6480464 | CTD | |
| G | ZNF358 | zinc finger protein 358 |
|
multiple interactions | EXP | 19 | 7,581,004 | 7,585,911 | RGD:6480464 | CTD | |
| G | ZNF358 | zinc finger protein 358 |
|
increases expression | EXP | 19 | 7,581,004 | 7,585,911 | RGD:6480464 | CTD | |
| G | ZNF492 | zinc finger protein 492 |
|
decreases expression | EXP | 19 | 22,817,126 | 22,850,472 | RGD:6480464 | CTD | |
| G | ZNF500 | zinc finger protein 500 |
|
increases expression | EXP | 16 | 4,800,815 | 4,817,166 | RGD:6480464 | CTD | |
| G | ZNF552 | zinc finger protein 552 |
|
decreases expression | EXP | 19 | 58,318,450 | 58,326,281 | RGD:6480464 | CTD | |
| G | ZNF571 | zinc finger protein 571 |
|
increases expression | EXP | 19 | 38,055,155 | 38,085,673 | RGD:6480464 | CTD | |
| G | ZNF573 | zinc finger protein 573 |
|
multiple interactions | EXP | 19 | 38,229,203 | 38,270,230 | RGD:6480464 | CTD | |
| G | ZNF573 | zinc finger protein 573 |
|
decreases expression | EXP | 19 | 38,229,203 | 38,270,230 | RGD:6480464 | CTD | |
| G | ZNF580 | zinc finger protein 580 |
|
multiple interactions | EXP | 19 | 56,152,392 | 56,154,836 | RGD:6480464 | CTD | |
| G | ZNF580 | zinc finger protein 580 |
|
increases expression | EXP | 19 | 56,152,392 | 56,154,836 | RGD:6480464 | CTD | |
| G | ZNF586 | zinc finger protein 586 |
|
multiple interactions | EXP | 19 | 58,281,020 | 58,291,984 | RGD:6480464 | CTD | |
| G | ZNF586 | zinc finger protein 586 |
|
decreases expression | EXP | 19 | 58,281,020 | 58,291,984 | RGD:6480464 | CTD | |
| G | ZNF692 | zinc finger protein 692 |
|
multiple interactions | EXP | 1 | 249,144,203 | 249,153,315 | RGD:6480464 | CTD | |
| G | ZNF768 | zinc finger protein 768 |
|
increases expression | EXP | 16 | 30,535,322 | 30,537,910 | RGD:6480464 | CTD | |
| G | ZNF839 | zinc finger protein 839 |
|
multiple interactions | EXP | 14 | 102,783,714 | 102,809,511 | RGD:6480464 | CTD | |
| G | ZNF85 | zinc finger protein 85 |
|
multiple interactions | EXP | 19 | 21,106,059 | 21,133,503 | RGD:6480464 | CTD | |
| G | ZNF85 | zinc finger protein 85 |
|
decreases expression | EXP | 19 | 21,106,059 | 21,133,503 | RGD:6480464 | CTD | |
| G | ZNF91 | zinc finger protein 91 |
|
decreases expression | EXP | 19 | 23,540,498 | 23,578,269 | RGD:6480464 | CTD | |
| G | ZWINT | ZW10 interactor, kinetochore protein |
|
decreases expression | EXP | 10 | 58,117,199 | 58,121,034 | RGD:6480464 | CTD | |
| G | ZYX | zyxin |
|
increases expression | EXP | 7 | 143,078,360 | 143,088,204 | RGD:6480464 | CTD | |
| G | ZYX | zyxin |
|
multiple interactions | EXP | 7 | 143,078,360 | 143,088,204 | RGD:6480464 | CTD | |
| G | ZZEF1 | zinc finger, ZZ-type with EF-hand domain 1 |
|
increases expression | EXP | 17 | 3,907,739 | 4,046,253 | RGD:6480464 | CTD | |
| G | ZZEF1 | zinc finger, ZZ-type with EF-hand domain 1 |
|
multiple interactions | EXP | 17 | 3,907,739 | 4,046,253 | RGD:6480464 | CTD | |
Term paths to the root
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




browse the term